≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Vitamin B12 deficiency anaemia

DOID EFO Endpoint Browser PheWeb

D3_ANAEMIA_B12_DEF

vitamin B12 deficiency: A disease characterized by low serum levels of vitamin B12, either inherited or acquired.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — D51
  • Hospital discharge: ICD-9 — 281[0-1]
  • Hospital discharge: ICD-8 — 281[0-1]
  • Cause of death: ICD-10 — D51
  • Cause of death: ICD-9 — 281[0-1]
  • Cause of death: ICD-8 — 281[0-1]
  • KELA reimbursements: KELA codes — 107

3 out of 7 registries used, show all original rules.

4568

4. Check minimum number of events

None

4568

5. Include endpoints

None

4568

6. Filter based on genotype QC (FinnGen only)

4568

Control definitions (FinnGen only)

Control exclude
D3_NUTRIANAEMIA

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D50-D53
Name in latin
Anaemia ex deficientia vitamini B12

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 52228 29010 22438
Only index persons 35116 20477 14639
Unadjusted period prevalence (%)
Whole population 0.74 0.83 0.63
Only index persons 0.67 0.75 0.56
Median age at first event (years)
Whole population 69.57 69.67 69.40
Only index persons 67.32 66.96 67.81

-FinnGen-

Key figures

All Female Male
Number of individuals 4568 2308 2260
Unadjusted period prevalence (%) 0.89 0.79 1.00
Median age at first event (years) 62.07 57.97 66.27

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
4136
Matched controls
41350
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D51.9
ICD-10 Finland
Vitamin B12deficiency anaemia, unspecified
217.9
323.0
1116
70
107
Kela drug reimbursment
Pernicious anaemia
+∞
323.0
3049
*
B81
ICPC
Anaemia vit B12/folate deficiency
81.4
323.0
2133
533
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
5.2
323.0
2180
7299
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
23.3
323.0
662
336
D51.0
ICD-10 Finland
Vitamin B12deficiency anaemia due to intrinsic factor deficiency
654.1
323.0
754
14
B03BA03
ATC
hydroxocobalamin; parenteral
248.3
323.0
3549
981
B03BA02
ATC
cyanocobalamin tannin complex; parenteral
76.6
323.0
377
54
K29.4
ICD-10 Finland
Chronic atrophic gastritis
41.3
323.0
1028
328
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
41.7
268.0
338
88
JDD00
NOMESCO Finland
Total gastrectomy and Roux-en-Y oesophagojejunostomy
210.6
249.6
257
13
T91
ICPC
Vitamin/nutritional deficiency
36.4
204.8
266
78
D64.9
ICD-10 Finland
Anaemia, unspecified
4.3
193.2
827
2294
SPAT1256
SPAT
Intramuscular and subcutaneous injection
2.7
193.1
2143
11822
D51
ICD-10 Finland
Vitamin B12deficiency anaemia
54.2
188.6
226
44
-50
ICPC
Medication/prescr/renewal
6.7
177.8
484
798
D51.8
ICD-10 Finland
Other vitamin B12deficiency anaemias
198.0
165.2
171
9
C16.9
ICD-10 Finland
Malignant neoplasm: Stomach, unspecified
28.5
142.3
196
72
B03BA01
ATC
cyanocobalamin; nasal, systemic
1355.0
135.1
131
*
E53.8
ICD-10 Finland
Deficiency of other specified B group vitamins
25.4
120.4
171
70
H03AA01
ATC
levothyroxine sodium; systemic
2.4
113.3
1207
6024
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
19.0
106.1
165
90
104
Kela drug reimbursment
Thyroid insufficiency
3.6
105.6
530
1624
A50
ICPC
General and Unspecified, Medication/prescr/renewal
5.8
103.5
310
567
B50
ICPC
Blood and Immunity, Medication/prescr/renewal
70.6
102.0
117
17
A55
ICPC
General and Unspecified, Local injection/infiltration
17.3
100.7
162
97
UJF32
NOMESCO Finland
Coloscopy
2.2
98.5
1264
6816
K50.0
ICD-10 Finland
Crohn disease of small intestine
14.6
96.4
166
118
D13.1
ICD-10 Finland
Benign neoplasm: Stomach
7.5
88.3
217
302
WVA30
SPAT
NA
6.8
88.1
233
361
K50.8
ICD-10 Finland
Other Crohn disease
12.8
86.7
158
128
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
2.7
85.2
667
2753
8140/3-C16.9
ICD-O-3
Adenocarcinoma, NOS, of stomach, NOS
35.3
84.6
110
32
376
Kela drug reimbursment
Cyanocobalamin
824.4
82.8
81
*
SPAT1254
SPAT
Administration of medicine
2.4
79.6
815
3882
2810X
ICD-9 Finland
Other deficiency anaemias, Pernicious anaemia[ANAEMIA PERNICIOSA SINE MYELOPATHIA SPINALI]
+∞
78.4
75
*
8145/3-C16.9
ICD-O-3
Carcinoma, diffuse type of stomach, NOS
62.0
77.9
91
15
D50.8
ICD-10 Finland
Other iron deficiency anaemias
18.4
72.1
113
63
B82
ICPC
Anaemia other/unspecified
6.2
71.4
201
338
UJF30
NOMESCO Finland
Ileoscopy through colon
2.9
66.2
447
1666
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.8
65.5
1536
10108
K50.9
ICD-10 Finland
Crohn disease, unspecified
9.4
64.6
137
150
UJD02
NOMESCO Finland
Gastroscopy
3.5
63.7
326
1000
C16.23
ICD-10 Finland
Malignant tumor of the corpus ventriculi diffuse carcinoma
73.4
63.3
72
10
L04AX01
ATC
azathioprine; systemic
4.3
59.6
236
580
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
4.3
59.3
233
568
A07EA06
ATC
budesonide; oral, local oral
4.9
59.0
202
428
C16.00
ICD-10 Finland
Cardia
22.6
56.3
82
37
K50.1
ICD-10 Finland
Crohn disease of large intestine
10.2
55.3
112
113
C16.20
ICD-10 Finland
Malignant tumor of the corpus ventriculi without histology
50.7
54.1
65
13
C10AC01
ATC
colestyramine; oral
4.6
52.0
190
431
B80
ICPC
Iron deficiency anaemia
6.8
51.3
134
204
6322
FHL
Gastrectomy (including Roux-Y)
503.8
50.5
50
*
C16.29
ICD-10 Finland
Malignant tumor of the corpus ventriculi other or unspecified carcinoma
58.8
49.5
58
10
-55
ICPC
Local injection/infiltration
9.7
49.1
102
108
D37.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Stomach
10.2
48.7
98
98
S50
ICPC
Skin, Medication/prescr/renewal
9.6
48.4
101
108
C16.39
ICD-10 Finland
Malignant tumor of the antrum ventriculi other or unspecified carcinoma
40.6
47.9
60
15
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.7
47.0
1334
9071
130
Kela drug reimbursment
Malignant tumour
2.4
47.0
451
2036
C16.2
ICD-10 Finland
Malignant neoplasm: Body of stomach
32.6
46.4
61
19
TPH04
NOMESCO Finland
Cathetrisation of vein
1.8
46.2
885
5314
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
2.6
45.6
364
1490
ZX120
NOMESCO Finland
Intravenous
2.3
45.1
441
2006
UJF92
NOMESCO Finland
Capsular endoscopy
8.6
44.8
99
117
A10AE04
ATC
insulin glargine; parenteral
2.3
42.8
439
2044
JDA05
NOMESCO Finland
Endoscopic polypectomy in stomach or pylorus
19.7
42.2
64
33
C16.30
ICD-10 Finland
Malignant tumor of the antrum ventriculi without histology
36.4
42.2
54
15
C16.33
ICD-10 Finland
Malignant tumor of the antrum ventriculi diffuse carcinoma
93.0
41.8
46
5
JFB00
NOMESCO Finland
Partial resection of small intestine
5.5
41.1
125
232
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.3
40.4
215
677
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.0
40.2
558
2959
C16.24
ICD-10 Finland
Malignant tumor of the corpus ventriculi intestinal carcinoma
52.8
39.5
47
9
8240/3-C16.9
ICD-O-3
Neuroendocrine tumor, NOS, of stomach, NOS
138.0
38.8
41
*
JKA20
NOMESCO Finland
Cholecystectomy
3.4
37.9
189
566
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
3.6
37.9
177
503
A07EC02
ATC
mesalazine; oral, rectal
3.0
37.9
238
838
A03FA01
ATC
metoclopramide; systemic, rectal
1.7
37.9
851
5337
JF1CG
NOMESCO Finland
Extensive MRI of small bowel
18.4
37.5
58
32
C16.09
ICD-10 Finland
Malignant tumor of cardiac or other unspecified carcinoma
18.6
37.0
57
31
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.5
36.3
1739
13281
A09AA02
ATC
multienzymes (lipase, protease etc.)
4.4
35.7
135
318
C16
ICD-10 Finland
Malignant neoplasm of stomach
181.5
34.8
36
*
B81
ICD-10 Finland
Other intestinal helminthiases, not elsewhere classified
124.4
34.7
37
*
D50
ICPC
Digestive, Medication/prescr/renewal
39.5
34.3
43
11
T89
ICPC
Diabetes insulin dependent
3.6
34.1
158
446
D53.1
ICD-10 Finland
Other megaloblastic anaemias, not elsewhere classified
31.7
33.5
44
14
S55
ICPC
Skin, Local injection/infiltration
23.7
33.1
47
20
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
5.4
32.7
100
188
56300
ICD-8 Finland
Chronic enteritis and ulcerative colitis, Regional enteritis
24.4
32.7
46
19
WX408
NOMESCO Finland
General anesthesy, balanced
1.6
32.6
971
6557
C16.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of stomach
22.6
32.6
47
21
5552A
ICD-9 Finland
Regional enteritis, Small intestine with large intestine
49.2
32.5
39
8
L01BC06
ATC
capecitabine; oral
3.1
32.5
187
623
28110
ICD-8 Finland
Other vitamin B12 deficiency anaemia, Other vitamin B12 deficiency
+∞
32.3
31
*
C16.34
ICD-10 Finland
Malignant tumor of the antrum ventriculi intestinal carcinoma
62.2
32.0
37
6
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.0
31.6
444
2355
E03.80
ICD-10 Finland
Hypothyroidism caused by autoimmune thyroiditis
5.1
31.3
101
202
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
3.0
31.2
187
641
A02BC02
ATC
pantoprazole; systemic
1.5
31.2
2450
20538
JN4BD
NOMESCO Finland
Extensive body CT
1.9
30.6
462
2516
28109
ICD-8 Finland
Other vitamin B12 deficiency anaemia, Perniciosa non definita
+∞
30.2
29
*
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.8
30.1
613
3697
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
2.1
29.9
372
1879
D51.1
ICD-10 Finland
Vitamin B12deficiency anaemia due to selective vitamin B12malabsorption with proteinuria
304.5
29.8
30
*
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.6
29.6
918
6243
A02BX02
ATC
sucralfate; oral
2.5
29.5
245
1018
R11
ICD-10 Finland
Nausea and vomiting
2.1
29.1
342
1681
C16.3
ICD-10 Finland
Malignant neoplasm: Pyloric antrum
31.9
29.0
38
12
JAH00
NOMESCO Finland
Laparotomy
3.2
29.0
156
496
R50.9
ICD-10 Finland
Fever, unspecified
1.8
28.8
549
3240
J01MA12
ATC
levofloxacin; systemic
1.6
28.8
776
5081
C03CA01
ATC
furosemide; systemic
1.5
28.7
1491
11404
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.1
28.6
339
1675
E03.89
ICD-10 Finland
Other specified hypothyroidism
3.0
28.6
167
563
Z01.8
ICD-10 Finland
Other specified special examinations
1.6
28.3
780
5132
JDF11
NOMESCO Finland
Laparoscopic gastric bypass
6.7
28.3
73
111
WX302
NOMESCO Finland
Thoracal epidural anesthesy
2.5
28.2
227
928
103
Kela drug reimbursment
Diabetes, insulin-treated
1.5
28.2
1144
8288
A03FA02
ATC
cisapride; oral, rectal
2.0
28.1
393
2077
5550A
ICD-9 Finland
Regional enteritis, Small intestine
39.2
28.0
35
9
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.8
28.0
493
2834
D50
ICD-10 Finland
Iron deficiency anaemia
5.8
27.7
80
141
D51.3
ICD-10 Finland
Other dietary vitamin B12deficiency anaemia
100.7
27.7
30
*
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
4.1
27.5
111
279
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
4.2
27.4
106
256
326
Kela drug reimbursment
Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)
14.1
27.0
46
33
C16.21
ICD-10 Finland
Malignant tumor of the corpus ventriculi early diffuse gastric carcinoma
75.6
26.8
30
*
SPAT1262
SPAT
Handing over of treatment supplies
1.6
26.5
715
4668
A10AE05
ATC
insulin detemir; parenteral
2.4
26.1
236
1029
R4190
NOMESCO Finland
Nutritional therapy
3.4
25.7
130
395
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
3.2
25.7
137
434
R53
ICD-10 Finland
Malaise and fatigue
1.6
25.6
832
5694
6403
FHL
Ileocal resection
58.4
25.0
29
5
D74
ICPC
Malignant neoplasm stomach
30.2
25.0
33
11
UJF02
NOMESCO Finland
Peroral enteroscopy
9.2
24.9
52
57
D52.9
ICD-10 Finland
Folate deficiency anaemia, unspecified
26.3
24.8
34
13
K91.2
ICD-10 Finland
Postsurgical malabsorption, not elsewhere classified
26.3
24.8
34
13
T50
ICPC
Metabolic, Medication/prescr/renewal
12.7
24.8
44
35
J01MA02
ATC
ciprofloxacin; systemic
1.4
24.5
1544
12165
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
3.2
24.3
129
407
N02BE01
ATC
paracetamol; systemic, rectal
1.5
24.1
3241
29339
2809X
ICD-9 Finland
Iron deficiency anaemias, Iron deficiency anaemia, unspecified
+∞
24.0
23
*
JDD96
NOMESCO Finland
Total gastrectomy with other reconstruction
+∞
24.0
23
*
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.5
23.9
986
7119
XW000
NOMESCO Finland
Bone marrow biopsy
2.6
23.8
177
695
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
4.2
23.7
91
219
WVA20
SPAT
NA
6.6
23.5
61
94
JDC20
NOMESCO Finland
Partial gastrectomy and Roux-en-Y reconstruction
21.4
23.4
34
16
K91.1
ICD-10 Finland
Postgastric surgery syndromes
33.6
23.3
30
9
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.7
23.2
550
3455
RD210
NOMESCO Finland
NA
4.3
23.1
87
206
JAH01
NOMESCO Finland
Laparoscopy
2.7
22.9
161
611
8145/3-C16.2
ICD-O-3
Carcinoma, diffuse type of body of stomach
83.9
22.7
25
*
8480/3-C16.9
ICD-O-3
Mucinous adenocarcinoma of stomach, NOS
45.2
22.3
27
6
SPAT1255
SPAT
Intravenous administration of medicine
2.1
22.3
271
1354
E53.9
ICD-10 Finland
Vitamin B deficiency, unspecified
16.8
22.2
35
21
TPH07
NOMESCO Finland
Cathetrisation of artery
1.8
22.1
409
2380
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.5
22.0
1089
8143
JFB33
NOMESCO Finland
Other resection comprising small intestine and colon
15.1
21.9
36
24
8140/3-C16.0
ICD-O-3
Adenocarcinoma, NOS, of cardia, NOS
13.2
21.9
38
29
ZXE20
NOMESCO Finland
More than three and less than five hours
1.7
21.9
549
3503
K50
ICD-10 Finland
Crohn disease [regional enteritis]
17.1
21.7
34
20
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.3
21.7
214
972
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.6
21.6
575
3726
8144/3-C16.9
ICD-O-3
Adenocarcinoma, intestinal type of stomach, NOS
115.6
21.6
23
*
B01AB05
ATC
enoxaparin; parenteral
1.4
21.2
1123
8503
C16.4
ICD-10 Finland
Malignant neoplasm: Pylorus
17.9
20.8
32
18
C16.03
ICD-10 Finland
Malignant tumor of cardiac diffuse carcinoma
19.5
20.8
31
16
JDW97
NOMESCO Finland
Other laparoscopic operation on stomach or duodenum
37.4
20.8
26
7
8144/3-C16.2
ICD-O-3
Adenocarcinoma, intestinal type of body of stomach
211.0
20.6
21
*
A28
ICPC
Limited function/disability NOS
1.5
20.5
695
4776
JFB20
NOMESCO Finland
Ileocaecal resection
8.3
20.4
45
55
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.6
20.2
562
3681
AA1AD
NOMESCO Finland
CT of head and brain
1.5
20.1
931
6848
JN3AD
NOMESCO Finland
Abdominal CT examination
1.9
19.9
290
1552
3AC01
NOMESCO Finland
NA
5.8
19.9
56
97
N02AA05
ATC
oxycodone; systemic
1.6
19.8
617
4152
28009
ICD-8 Finland
Iron deficiency anaemias, Unspecified
+∞
19.8
19
*
2811A
ICD-9 Finland
Other deficiency anaemias, Other vitamin B12 deficiency anaemia
+∞
19.8
19
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.6
19.8
586
3898
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.5
19.6
693
4806
TPX10
NOMESCO Finland
Implantation of vascular injection port
2.8
19.5
125
450
E66.8
ICD-10 Finland
Other obesity
2.5
19.4
157
646
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.4
19.4
1065
8091
C16.01
ICD-10 Finland
Malignant tumor in cardia early diffuse gastric carcinoma early diffuse gastric carcinoma
31.4
19.2
25
8
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.4
19.1
1180
9160
E87.6
ICD-10 Finland
Hypokalaemia
2.6
19.0
137
529
A10AA01
ATC
NA
3.1
19.0
106
349
M05BA04
ATC
alendronic acid; oral
1.7
18.9
391
2354
H02AB06
ATC
prednisolone; systemic
1.4
18.8
1692
13983
2810A
ICD-9 Finland
Other deficiency anaemias, Pernicious anaemia[ANAEMIA PERNICIOSA CUM MYELOPATHIA SPINALI]
+∞
18.8
18
*
N03AX16
ATC
pregabalin; oral
1.5
18.7
798
5762
JF1BD
NOMESCO Finland
Very extensive small bowel CT
7.4
18.6
44
60
WW500
NOMESCO Finland
Blood transfusion
2.5
18.5
148
605
K29.3
ICD-10 Finland
Chronic superficial gastritis
2.5
18.5
144
580
SPAT1263
SPAT
Sampling
1.4
18.1
1470
11929
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.7
18.0
396
2429
E27.1
ICD-10 Finland
Primary adrenocortical insufficiency
15.4
17.9
29
19
J01DB01
ATC
cefalexin; oral
1.4
17.9
2866
25812
A07DA03
ATC
loperamide; oral
2.3
17.9
173
781
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
3.7
17.8
77
209
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
1.8
17.6
292
1635
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
4.0
17.5
70
177
JF1DG
NOMESCO Finland
Small bowel very extensive MRI with with high intensity magnet
15.6
17.5
28
18
A10BH01
ATC
sitagliptin; oral
1.7
17.4
364
2197
A04AA02
ATC
granisetron; systemic, transdermal
2.0
17.2
213
1071
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
2.9
17.2
104
360
E0000UV
ATC
NA
1.4
17.1
1309
10495
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.4
17.0
1021
7852
C16.5
ICD-10 Finland
Malignant neoplasm: Lesser curvature of stomach, unspecified
25.7
16.9
23
9
ZXD05
NOMESCO Finland
Urgent procedure
1.4
16.9
1107
8642
H3600, E103
ICD-10 Finland
NA
6.6
16.9
43
66
K29.5
ICD-10 Finland
Chronic gastritis, unspecified
2.6
16.7
127
506
2800A
ICD-9 Finland
Iron deficiency anaemias, Secondary to blood loss (chronic)
+∞
16.7
16
*
H02AB07
ATC
prednisone; oral
1.5
16.6
545
3706
A10BA02
ATC
metformin; oral
1.4
16.5
1078
8407
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.2
16.4
173
812
C16.31
ICD-10 Finland
Malignant tumor of the antrum ventriculi early diffuse gastric carcinoma
40.2
16.3
20
5
JDA55
NOMESCO Finland
Endoscopic dilatation of stomach, pylorus or anastomosis of stomach
12.2
16.3
29
24
A07EC01
ATC
sulfasalazine; oral, rectal
1.8
16.3
266
1484
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.3
16.2
1397
11387
E000001
ATC
NA
1.5
16.2
682
4895
A41.9
ICD-10 Finland
Sepsis, unspecified
2.2
16.1
163
749
K29.7
ICD-10 Finland
Gastritis, unspecified
2.3
16.1
147
643
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
2.2
16.0
160
734
6402
FHL
Small bowel resection
9.5
15.9
32
34
D51.2
ICD-10 Finland
Transcobalamin II deficiency
85.4
15.6
17
*
R06.0
ICD-10 Finland
Dyspnoea
1.4
15.5
909
6941
A07AA02
ATC
nystatin; oral
1.8
15.5
254
1418
K90.0
ICD-10 Finland
Coeliac disease
2.6
15.4
112
436
JF1AD
NOMESCO Finland
Small bowel CT
8.5
15.4
33
39
N02AX02
ATC
tramadol; systemic, rectal
1.3
15.4
1518
12603
A04
ICPC
Weakness/tiredness general
1.6
15.4
475
3180
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
2.4
15.3
133
570
A10BB12
ATC
glimepiride; oral
1.7
15.2
340
2091
WX110
NOMESCO Finland
Local anesthesy
1.3
15.1
2142
18704
E03
ICD-10 Finland
Other hypothyroidism
2.0
15.1
201
1042
8240/3-C16.2
ICD-O-3
Neuroendocrine tumor, NOS, of body of stomach
45.1
15.0
18
*
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
1.6
15.0
391
2510
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
1.9
14.8
235
1296
T90
ICPC
Diabetes non-insulin dependent
1.4
14.8
803
6042
K80.5
ICD-10 Finland
Calculus of bile duct without cholangitis or cholecystitis
2.4
14.8
127
541
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
2.2
14.8
144
654
H02AB09
ATC
hydrocortisone; systemic
3.0
14.8
86
293
C16.22
ICD-10 Finland
Malignant tumor of the corpus ventriculi early intestinal gastric carcinoma
56.9
14.8
17
*
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.5
14.6
579
4098
E10.8
ICD-10 Finland
Type 1 diabetes mellitus, With unspecified complications
4.6
14.6
50
110
WX002
NOMESCO Finland
Sedation and analgesia
1.4
14.6
696
5111
B55
ICPC
Blood and Immunity, Local injection/infiltration
80.4
14.6
16
*
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
1.8
14.5
272
1586
K02.1
ICD-10 Finland
Caries of dentine
1.3
14.4
1590
13377
105
Kela drug reimbursment
Adrenal cortical hypofunction
15.4
14.4
23
15
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
1.6
14.3
369
2357
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.6
14.3
355
2246
E86
ICD-10 Finland
Volume depletion
2.3
14.2
126
548
H04AA01
ATC
glucagon; nasal, parenteral
3.4
14.1
69
208
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
1.9
14.1
208
1119
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
1.8
14.1
247
1409
JAP00
NOMESCO Finland
Freeing of adhesions in the peritoneal cavity
4.0
14.0
55
138
C16.0
ICD-10 Finland
Malignant neoplasm: Cardia
9.4
13.9
28
30
E10
ICD-10 Finland
Type 1 diabetes mellitus
3.7
13.9
60
164
P01AB01
ATC
metronidazole; oral, rectal
1.3
13.9
1252
10214
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
2.6
13.9
99
383
T86
ICPC
Hypothyroidism/myxoedema
2.2
13.9
141
655
XCK10
NOMESCO Finland
Photography of fundus of eye
1.6
13.9
381
2475
E66.9
ICD-10 Finland
Obesity, unspecified
2.6
13.8
99
385
S97
ICPC
Chronic ulcer skin
1.9
13.8
209
1136
N06AX11
ATC
mirtazapine; oral
1.3
13.8
1041
8272
J02AC01
ATC
fluconazole; systemic
1.3
13.7
1176
9523
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.0
13.6
175
893
A10AE06
ATC
insulin degludec; parenteral
2.9
13.6
84
297
Z71.8
ICD-10 Finland
Other specified counselling
1.4
13.6
677
5007
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.4
13.5
742
5582
D59.1
ICD-10 Finland
Other autoimmune haemolytic anaemias
7.9
13.5
30
38
SPAT1203
SPAT
Injection therapy, other than intramuscular or subcutaneous
2.0
13.5
170
861
K25.9
ICD-10 Finland
Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation
2.9
13.5
83
292
K56.7
ICD-10 Finland
Ileus, unspecified
2.9
13.5
81
283
JFA38
NOMESCO Finland
Endoscopic dilatation of small intestine
34.1
13.5
17
5
K80.0
ICD-10 Finland
Calculus of gallbladder with acute cholecystitis
1.9
13.5
185
972
UJF12
NOMESCO Finland
Enteroscopy through intestinal stoma
10.9
13.5
25
23
5559X
ICD-9 Finland
Regional enteritis, Unspecified site
140.4
13.4
14
*
A01AB09
ATC
miconazole; local oral
1.6
13.3
346
2215
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.4
13.2
716
5375
C07AB07
ATC
bisoprolol; oral
1.3
13.2
1892
16416
C16.04
ICD-10 Finland
Malignant tumor of cardiac intestinal carcinoma
13.8
13.2
22
16
R13
ICD-10 Finland
Dysphagia
1.8
13.2
241
1394
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.6
13.2
389
2574
K51.0
ICD-10 Finland
Ulcerative (chronic) pancolitis
5.8
13.1
36
62
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.3
13.0
1509
12726
E10.1
ICD-10 Finland
Type 1 diabetes mellitus, With ketoacidosis
6.2
13.0
34
55
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.6
13.0
370
2428
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
2.1
13.0
144
696
E61.1
ICD-10 Finland
Iron deficiency
4.8
12.9
42
88
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.3
12.9
1182
9643
L04AB04
ATC
adalimumab; parenteral
3.5
12.9
58
165
C16.32
ICD-10 Finland
Malignant tumor of the antrum ventriculi early intestinal gastric carcinoma
50.1
12.8
15
*
E10.00
ICD-10 Finland
Insulin-dependent diabetes diabetic hypoglycemic coma
4.5
12.8
44
98
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
1.7
12.8
253
1503
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
1.8
12.8
206
1144
K25.7
ICD-10 Finland
Gastric ulcer, Chronic without haemorrhage or perforation
3.7
12.8
55
151
A02BC03
ATC
lansoprazole; oral
1.3
12.7
1071
8635
T55
ICPC
Metabolic, Local injection/infiltration
32.1
12.6
16
5
A11CC03
ATC
alfacalcidol; systemic
2.5
12.5
97
392
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
3.3
12.5
62
190
K31.8
ICD-10 Finland
Other specified diseases of stomach and duodenum
5.5
12.5
36
66
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
1.6
12.5
347
2263
A02BA02
ATC
ranitidine; systemic
1.4
12.5
777
5968
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.3
12.5
1046
8418
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
3.6
12.5
55
154
D13.3
ICD-10 Finland
Benign neoplasm: Other and unspecified parts of small intestine
6.6
12.5
31
47
O99.0
ICD-10 Finland
Anaemia complicating pregnancy, childbirth and the puerperium
9.3
12.4
25
27
6321
FHL
Subtotal gastrectomy (also includes oment and spleen removal)
130.4
12.4
13
*
D50.1
ICD-10 Finland
Sideropenic dysphagia
130.4
12.4
13
*
JN4AD
NOMESCO Finland
Body CT examination
1.7
12.4
260
1569
SPAT1130
SPAT
Esophagoscopy, gastroscopy and duodenoscopy
2.3
12.4
109
474
R42
ICD-10 Finland
Dizziness and giddiness
1.4
12.4
818
6345
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.5
12.4
503
3573
I50.9
ICD-10 Finland
Heart failure, unspecified
1.4
12.4
664
4973
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.7
12.3
246
1466
J01FF01
ATC
clindamycin; systemic
1.4
12.3
848
6619
25000
ICD-8 Finland
Diabetes mellitus, Sine complicatione
2.2
12.3
119
541
B03XA02
ATC
darbepoetin alfa; parenteral
2.8
12.2
80
293
JFA58
NOMESCO Finland
Endoscopic dilatation of colon
9.6
12.2
24
25
L01BC53
ATC
tegafur, combinations; systemic
12.4
12.1
21
17
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
3.7
12.1
52
143
JN4CD
NOMESCO Finland
Very extensive body CT
2.0
12.0
151
768
JMA10
NOMESCO Finland
Transabdominal total splenectomy
4.8
12.0
39
82
A04AA01
ATC
ondansetron; systemic, rectal
1.8
12.0
213
1224
EBA00
NOMESCO Finland
Extraction of tooth
1.3
12.0
950
7573
JDA52
NOMESCO Finland
Other endoscopic procedure using diathermy or heat in stomach or pylorus
11.0
12.0
22
20
JCA55
NOMESCO Finland
Endoscopic dilatation of oesophagus
3.6
12.0
53
149
SPAT1310
SPAT
Counselling related to known health issue
1.3
12.0
1012
8147
E10.4
ICD-10 Finland
Type 1 diabetes mellitus, With neurological complications
5.0
12.0
37
74
K92.1
ICD-10 Finland
Melaena
1.8
11.9
203
1150
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
1.8
11.9
203
1151
D11
ICPC
Diarrhoea
1.6
11.8
283
1776
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
2.5
11.8
87
346
178
Kela drug reimbursment
Combination product containing tegafur, gimeracil and oteracil
14.7
11.8
19
13
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
2.0
11.8
140
698
24409
ICD-8 Finland
Myxoedema, (hypothyreosis) NUD
8.4
11.8
25
30
D07AB02
ATC
hydrocortisone butyrate; topical
1.3
11.7
929
7403
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.4
11.7
524
3795
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.7
11.6
270
1678
R63.4
ICD-10 Finland
Abnormal weight loss
2.1
11.6
131
636
8145/3-C16.3
ICD-O-3
Carcinoma, diffuse type of gastric antrum
65.1
11.6
13
*
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
1.7
11.6
255
1562
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
1.9
11.5
177
971
A29
ICPC
General symptom/complaint other
1.5
11.5
389
2658
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.3
11.5
1578
13537
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
2.6
11.5
84
332
D55
ICPC
Digestive, Local injection/infiltration
120.3
11.4
12
*
C16.13
ICD-10 Finland
Malignant tumor of the fundus ventriculi diffuse carcinoma
120.3
11.4
12
*
A06AD11
ATC
lactulose; oral
1.4
11.4
640
4823
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
1.9
11.4
156
822
A06AC01
ATC
ispaghula (psylla seeds); oral
1.3
11.2
873
6933
A10AA02
ATC
NA
2.0
11.2
144
737
Z3231
NOMESCO Finland
Registered nurse
1.3
11.2
944
7584
Z3226
NOMESCO Finland
Physiotherapist
1.4
11.2
623
4690
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
2.4
11.1
89
369
R07.4
ICD-10 Finland
Chest pain, unspecified
1.3
11.1
950
7651
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.4
11.1
553
4079
R4110
NOMESCO Finland
Physiotherapy
1.3
11.1
876
6974
K25.4
ICD-10 Finland
Gastric ulcer, Chronic or unspecified with haemorrhage
3.9
11.0
44
114
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
1.9
10.8
149
783
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.3
10.8
1129
9337
L80
ICD-10 Finland
Vitiligo
6.9
10.8
26
38
JX1LA
NOMESCO Finland
Kinetic X-ray of alimentary tract with pictures
15.5
10.8
17
11
SFA40
NOMESCO Finland
Replacement of krone of tooth
1.4
10.8
625
4735
A01AB04
ATC
amphotericin B; local oral
1.8
10.8
198
1150
N30.0
ICD-10 Finland
Acute cystitis
1.4
10.7
482
3486
K08.3
ICD-10 Finland
Retained dental root
1.7
10.7
222
1338
6318
FHL
Resection (2/3) and gastrojejunostomy (including Roux-Y)
9.6
10.7
21
22
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
3.0
10.7
59
197
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
2.0
10.7
125
620
L28
ICPC
Limited function/disability (L)
1.4
10.6
606
4580
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.7
10.6
216
1297
I10
ICD-10 Finland
Essential (primary) hypertension
1.2
10.6
2288
20624
N03AX12
ATC
gabapentin; oral
1.4
10.6
481
3492
Z93.2
ICD-10 Finland
Ileostomy status
7.0
10.5
25
36
D46.9
ICD-10 Finland
Myelodysplastic syndrome, unspecified
4.8
10.5
34
72
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
4.8
10.5
34
72
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.4
10.4
544
4046
D00.2
ICD-10 Finland
Carcinoma in situ: Stomach
110.3
10.4
11
*
C16.19
ICD-10 Finland
Malignant tumor of the fundus ventriculi other or unspecified carcinoma
110.3
10.4
11
*
15199
ICD-8 Finland
Malignant neoplasm of stomach, Part unspecified
+∞
10.4
10
*
H02AA02
ATC
fludrocortisone; oral
3.5
10.4
47
136
N06AX21
ATC
duloxetine; oral
1.6
10.3
293
1919
JFF00
NOMESCO Finland
Catheter enterostomy
12.0
10.3
18
15
5551A
ICD-9 Finland
Regional enteritis, Large intestine
32.6
10.3
13
*
J01CA08
ATC
pivmecillinam; oral
1.3
10.3
1306
11057
B04AD01
ATC
NA
8.8
10.2
21
24
RD160
NOMESCO Finland
NA
9.6
10.2
20
21
A10BG03
ATC
pioglitazone; oral
2.3
10.2
94
417
P01BA02
ATC
hydroxychloroquine; oral
1.6
10.2
245
1539
K59.1
ICD-10 Finland
Functional diarrhoea
1.8
10.2
173
979
Z51.5
ICD-10 Finland
Palliative care
1.6
10.2
233
1445
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
1.4
10.1
503
3707
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
2.0
10.1
131
674
E66.01
ICD-10 Finland
Obesity due to excess calories
1.8
10.1
172
979
SPAT1325
SPAT
Vaccination
1.3
10.0
1263
10678
QBJ30
NOMESCO Finland
Correction of abdominal apron
4.9
10.0
31
63
D64.8
ICD-10 Finland
Other specified anaemias
2.7
10.0
67
252
N19
ICD-10 Finland
Unspecified kidney failure
1.9
9.9
148
802
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
2.6
9.9
69
267
D28
ICPC
Limited function/disability (D)
5.8
9.9
27
47
E83.51
ICD-10 Finland
Hypocalcemia
5.5
9.9
28
51
D06
ICPC
Abdominal pain localized other
1.6
9.9
232
1449
L01BB02
ATC
mercaptopurine; oral
4.9
9.9
31
64
K86.1
ICD-10 Finland
Other chronic pancreatitis
3.8
9.9
40
106
XJD02
NOMESCO Finland
Peroral endoscopic ultrasonography
3.7
9.9
41
111
N18.8
ICD-10 Finland
Other chronic renal failure
2.1
9.8
114
563
Z2221
NOMESCO Finland
Medical doctor
1.3
9.8
908
7373
K90.3
ICD-10 Finland
Pancreatic steatorrhoea
4.7
9.8
32
69
D62
ICD-10 Finland
Acute posthaemorrhagic anaemia
3.5
9.7
44
128
-1
NOMESCO Finland
NA
1.3
9.7
856
6906
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
1.5
9.7
290
1925
A10BH05
ATC
linagliptin; oral
1.7
9.7
186
1096
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
1.7
9.6
182
1071
R55
ICD-10 Finland
Syncope and collapse
1.4
9.6
418
3008
SPAT1301
SPAT
No procedures
1.3
9.5
1093
9123
TBW99
NOMESCO Finland
Other minor procedure in endocrine surgery
15.0
9.5
15
10
ZXE10
NOMESCO Finland
More than one and less than three hours
1.3
9.5
1243
10545
SAA02
NOMESCO Finland
Basic examination of mouth
1.2
9.4
1772
15649
384
Kela drug reimbursment
Combination product containing tegafur, gimeracil and oteracil
100.2
9.4
10
*
8140/3-C16.3
ICD-O-3
Adenocarcinoma, NOS, of gastric antrum
30.1
9.4
12
*
8145/3-C16.0
ICD-O-3
Carcinoma, diffuse type of cardia, NOS
30.1
9.4
12
*
28000
ICD-8 Finland
Iron deficiency anaemias, Posthaemorrhagica
+∞
9.4
9
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
1.9
9.4
132
705
2501B
ICD-9 Finland
Diabetes mellitus, Diabetes with ketoacidosis[DIABETES MELLITUS CUM KETOACIDOSI ,TYYPPI I]
12.3
9.3
16
13
8144/3-C16.3
ICD-O-3
Adenocarcinoma, intestinal type of gastric antrum
21.7
9.3
13
6
M05BX04
ATC
denosumab; parenteral
1.7
9.3
185
1104
H02AB02
ATC
dexamethasone; systemic
1.5
9.3
324
2225
TKC20
NOMESCO Finland
Catheterisation of bladder
1.5
9.3
274
1813
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.6
9.3
254
1651
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
1.7
9.2
172
1008
WZC30
NOMESCO Finland
Teaching
1.4
9.2
386
2756
A01
ICPC
Pain general/multiple sites
1.6
9.2
242
1559
T28
ICPC
Limited function/disability (T)
3.4
9.1
42
124
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.4
9.1
558
4261
L04AC05
ATC
ustekinumab; parenteral
7.7
9.1
20
26
2449X
ICD-9 Finland
Acquired hypothyroidism, Unspecified hypothyroidism
6.2
9.1
23
37
E03.8
ICD-10 Finland
Other specified hypothyroidism
6.2
9.1
23
37
H36.09*E10.3
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic retinopathy
5.1
9.1
27
53
D94
ICPC
Chronic enteritis/ulcerative colitis
5.1
9.1
27
53
K29.9
ICD-10 Finland
Gastroduodenitis, unspecified
3.4
9.0
42
125
L17
ICPC
Foot/toe symptom/complaint
1.3
9.0
777
6240
C16.02
ICD-10 Finland
Malignant tumor of cardiac early intestinal gastric carcinoma
36.8
9.0
11
*
RD250
NOMESCO Finland
NA
36.8
9.0
11
*
K13.79
ICD-10 Finland
Change in the oral mucosa UNS
2.4
9.0
75
320
R56.8
ICD-10 Finland
Other and unspecified convulsions
1.8
9.0
146
821
B78
ICPC
Hereditary haemolytic anaemia
18.6
8.9
13
7
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.3
8.9
966
7996
U07
ICPC
Urine symptom/complaint other
1.7
8.9
191
1166
5351A
ICD-9 Finland
Gastritis and duodenitis, Atrophic gastritis[GASTRITIS ATROPHICANS CORPORIS (TYPUS A)]
24.0
8.9
12
5
WX704
NOMESCO Finland
Intubation
1.6
8.9
212
1329
E03.0
ICD-10 Finland
Congenital hypothyroidism with diffuse goitre
3.5
8.8
39
112
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.6
8.8
244
1590
E10.6
ICD-10 Finland
Type 1 diabetes mellitus, With other specified complications
4.9
8.8
27
55
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.3
8.8
596
4622
S72.0
ICD-10 Finland
Fracture of neck of femur
1.7
8.7
189
1156
K51.8
ICD-10 Finland
Other ulcerative colitis
3.3
8.7
42
129
JC2AB
NOMESCO Finland
Oesophagus X-ray examination with contrast
3.3
8.7
42
129
E11.2
ICD-10 Finland
Type 2 diabetes mellitus, with renal complications
1.9
8.7
126
678
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.2
8.7
1546
13534
1514C
ICD-9 Finland
Malignant neoplasm of stomach, Body of stomach[MAHASYÖPÄ, CORPORIS DIFFUUSI KARSINOOMA]
50.1
8.7
10
*
C16.6
ICD-10 Finland
Malignant neoplasm: Greater curvature of stomach, unspecified
50.1
8.7
10
*
2662A
ICD-9 Finland
Deficiency of B-complex components, Other B-complex deficiencies[HYPOVITAMINOSIS B12]
50.1
8.7
10
*
C16.10
ICD-10 Finland
Malignant tumor of the fundus ventriculi without histology
50.1
8.7
10
*
O99.2
ICD-10 Finland
Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium
4.5
8.6
29
65
N06AB04
ATC
citalopram; systemic
1.3
8.6
683
5419
TK800
NOMESCO Finland
Hemodialysis
2.4
8.6
72
307
E55.9
ICD-10 Finland
Vitamin D deficiency, unspecified
5.2
8.6
25
48
A03DA02
ATC
pitofenone and analgesics; systemic
2.1
8.6
95
462
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.3
8.5
742
5963
J45.9
ICD-10 Finland
Asthma, unspecified
1.3
8.5
561
4330
E66.00
ICD-10 Finland
Metabolic syndrome
1.8
8.5
142
804
JFF10
NOMESCO Finland
Loop enterostomy
4.0
8.5
32
80
T44
ICPC
Metabolic, Preventive immunization/medic
27.6
8.5
11
*
L95
ICPC
Osteoporosis
1.9
8.5
116
612
S52.5
ICD-10 Finland
Fracture of lower end of radius
1.5
8.5
308
2138
WX892
NOMESCO Finland
Monitored bed care
1.5
8.4
241
1590
E87.5
ICD-10 Finland
Hyperkalaemia
2.3
8.4
71
307
R10.0
ICD-10 Finland
Acute abdomen
2.0
8.4
98
487
D59.9
ICD-10 Finland
Acquired haemolytic anaemia, unspecified
7.9
8.3
18
23
28008
ICD-8 Finland
Iron deficiency anaemias, Alia definita
+∞
8.3
8
*
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
2.3
8.3
76
340
JDC10
NOMESCO Finland
Partial gastrectomy and gastrojejunostomy
10.7
8.3
15
14
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.3
8.3
604
4734
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.5
8.2
304
2117
D01
ICPC
Abdominal pain/cramps general
1.5
8.2
268
1817
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
1.5
8.2
322
2266
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.3
8.2
618
4867
A07EA02
ATC
hydrocortisone; rectal
2.3
8.2
73
323
JAD10
NOMESCO Finland
Repair of incisional hernia
3.6
8.2
35
98
E11
ICD-10 Finland
Type 2 diabetes mellitus
1.4
8.2
503
3841
ZX114
SPAT
NA
7.5
8.1
18
24
SPAT1100
SPAT
Long-term monitoring of blood pressure
1.5
8.1
269
1829
SAA01
NOMESCO Finland
Simple examination of mouth
1.2
8.1
2005
18105
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.4
8.1
495
3778
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.2
8.1
1427
12456
M07.4*K50.9
ICD-10 Finland
Arthropathy in Crohn's disease [regional enteritis]
11.7
8.1
14
12
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
1.4
8.0
449
3375
ZXA10
NOMESCO Finland
Bilateral
1.3
8.0
645
5126
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
2.1
8.0
91
448
R51.80
ICD-10 Finland
Headache
1.4
8.0
368
2672
JDF01
NOMESCO Finland
Laparoscopic gastroplasty
6.3
8.0
20
32
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
1.7
8.0
162
977
D87
ICPC
Stomach function disorder
7.2
7.9
18
25
KMAK
NOMESCO Finland
NA
1.2
7.9
1424
12444
2500B
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]
2.6
7.9
56
221
H3603, E103
ICD-10 Finland
NA
3.8
7.9
31
81
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.6
7.9
222
1455
ZXA05
NOMESCO Finland
Left side
1.3
7.9
921
7674
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
1.7
7.9
168
1027
H36.00
ICD-10 Finland
Diabetic background retinopathy
2.8
7.9
50
183
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
2.1
7.9
88
432
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.3
7.9
836
6889
H05AA02
ATC
teriparatide; parenteral
5.1
7.8
23
45
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.2
7.8
1475
12950
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
1.3
7.8
693
5578
ZXC86
NOMESCO Finland
Use of endoscopic device
4.3
7.8
27
63
K91.8
ICD-10 Finland
Other postprocedural disorders of digestive system, not elsewhere classified
10.8
7.8
14
13
Z01.2
ICD-10 Finland
Dental examination
1.2
7.8
1060
8993
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.5
7.8
288
2006
WX290
NOMESCO Finland
Other blockade of nerve
1.2
7.7
1029
8703
R06AE07
ATC
cetirizine; oral
1.2
7.7
1269
10983
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
2.2
7.7
77
358
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
1.6
7.7
171
1054
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
1.8
7.7
120
667
A12AA04
ATC
calcium carbonate; oral
2.5
7.7
57
231
UKC02
NOMESCO Finland
Cystoscopy
1.3
7.6
613
4868
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
2.1
7.6
86
422
N29
ICPC
Neurological sympt/complt other
2.4
7.6
61
258
A10BD03
ATC
metformin and rosiglitazone; systemic
2.5
7.6
57
232
D07AC01
ATC
betamethasone; topical
1.2
7.6
1091
9305
205
Kela drug reimbursment
Chronic hypertension
1.2
7.6
1212
10453
SPAT1104
SPAT
Monitoring of emergency patient
1.5
7.6
218
1436
K04.1
ICD-10 Finland
Necrosis of pulp
1.5
7.6
236
1585
N06AX03
ATC
mianserin; oral
1.7
7.5
161
984
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
1.8
7.5
126
718
5609X
ICD-9 Finland
Intestinal obstruction without mention of hernia, Unspecified intestinal obstruction
5.4
7.5
21
39
56096
ICD-8 Finland
Intestinal obstruction without mention of hernia, Ileus propter adhaesionem (functione laesa circulationis intestinalis non indicata)
5.4
7.5
21
39
BEF00
NOMESCO Finland
Continuous subcutaneous glucose monitoring
5.4
7.5
21
39
SAA03
NOMESCO Finland
Extended examination of mouth
1.2
7.5
998
8435
B28
ICPC
Limited function/disability (B)
4.3
7.5
26
61
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.4
7.5
410
3073
K22.2
ICD-10 Finland
Oesophageal obstruction
2.9
7.5
43
149
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
1.9
7.5
100
527
B99
ICD-10 Finland
Other and unspecified infectious diseases
2.2
7.5
73
339
N03AX09
ATC
lamotrigine; oral
2.0
7.4
89
448
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
1.4
7.4
313
2239
ZY010
NOMESCO Finland
Hospital outpatient
1.9
7.4
102
543
R52.2
ICD-10 Finland
Other chronic pain
2.0
7.4
91
464
2859X
ICD-9 Finland
Other and unspecified anaemias, Anaemia, unspecified[ANAEMIA NUD]
5.3
7.4
21
40
ZXE00
NOMESCO Finland
One hour or less
1.2
7.3
1286
11188
A10BX04
ATC
[U] exenatide; parenteral
3.3
7.3
35
108
N06AA09
ATC
amitriptyline; systemic
1.4
7.3
328
2371
2780A
ICD-9 Finland
Obesity and other hyperalimentation, Obesity
3.7
7.3
30
82
C03DA01
ATC
spironolactone; oral
1.4
7.3
402
3014
H02AB04
ATC
methylprednisolone; systemic
1.3
7.3
471
3620
SGA02
NOMESCO Finland
Opening and dilatation of root canal of tooth
1.4
7.3
300
2133
K81.0
ICD-10 Finland
Acute cholecystitis
2.1
7.3
74
348
1512C
ICD-9 Finland
Malignant neoplasm of stomach, Pyloric antrum[MAHASYÖPÄ, ANTRI PYLORI DIFFUUSI KARSINOOMA]
+∞
7.3
7
*
JFK10
NOMESCO Finland
Freeing of adhesions in intestinal obstruction
4.5
7.2
24
54
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.3
7.2
502
3904
D63.8
ICD-10 Finland
Anaemia in other chronic diseases classified elsewhere
5.8
7.2
19
33
N05AH04
ATC
quetiapine; oral
1.4
7.1
419
3176
SPAT1240
SPAT
Therapeutic discussion
1.5
7.1
212
1409
D53.9
ICD-10 Finland
Nutritional anaemia, unspecified
30.0
7.1
9
*
Z80.0
ICD-10 Finland
Family history of malignant neoplasm of digestive organs
3.9
7.1
27
69
1370
FHL
Colonoscopy, whole colon
3.8
7.1
28
74
AN1
HP
Coronary angiography
1.3
7.1
443
3387
ZXD10
NOMESCO Finland
Scheduled procedure
1.2
7.1
1310
11447
K55.8
ICD-10 Finland
Other vascular disorders of intestine
6.6
7.1
17
26
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.2
7.1
998
8485
R19.8
ICD-10 Finland
Other specified symptoms and signs involving the digestive system and abdomen
2.7
7.1
46
173
NFJ54
NOMESCO Finland
Internal fixation of fracture of upper femur with intramedullary nail
2.1
7.1
78
383
177
Kela drug reimbursment
Insulin glargine 300 U / ml
2.3
7.1
60
262
EBA30
NOMESCO Finland
Excision of root of tooth
1.6
7.1
158
980
H01CB02
ATC
octreotide; parenteral
6.0
7.1
18
30
EKA10
NOMESCO Finland
Biopsy of cheek
2.2
7.0
67
307
E11.4
ICD-10 Finland
Type 2 diabetes mellitus, with neurological complications
1.9
7.0
92
480
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
1.7
7.0
139
834
E10.5
ICD-10 Finland
Type 1 diabetes mellitus, With peripheral circulatory complications
4.7
7.0
22
47
SPAT1249
SPAT
Treatment-related counselling outside office
1.2
7.0
1219
10595
SPAT1260
SPAT
Consultation of another employee
1.3
6.9
549
4350
XJW99
NOMESCO Finland
Other investigative procedure on digestive system
5.1
6.9
20
39
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
1.8
6.9
113
638
JFB30
NOMESCO Finland
Right hemicolectomy
2.4
6.9
56
239
K80.8
ICD-10 Finland
Other cholelithiasis
2.4
6.9
56
239
Y0599
ICD-8 Finland
Investigation of digestive system
2.1
6.9
74
358
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.4
6.9
342
2519
K85
ICD-10 Finland
Acute pancreatitis
2.2
6.9
66
302
JFB96
NOMESCO Finland
Other partial excision of intestine
13.8
6.9
11
8
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.2
6.9
1356
11918
J01DA01
ATC
[U] cefalexin; systemic
1.2
6.9
2205
20266
J01MA14
ATC
moxifloxacin; systemic
1.4
6.8
279
1985
160
Kela drug reimbursment
exenatide
2.3
6.8
56
241
E89.00
ICD-10 Finland
Postirradiation hypothyroidism
3.1
6.8
34
109
UJK02
NOMESCO Finland
ERCP
1.9
6.8
95
510
J01EA01
ATC
trimethoprim; systemic
1.2
6.8
923
7810
R41.0
ICD-10 Finland
Disorientation, unspecified
1.7
6.8
121
702
B03XA03
ATC
methoxy polyethylene glycol-epoetin beta; parenteral
4.2
6.8
24
58
L01BB01
ATC
NA
9.3
6.8
13
14
K74.6
ICD-10 Finland
Other and unspecified cirrhosis of liver
2.8
6.8
40
143
A03
ICPC
Fever
1.4
6.8
344
2545
L88
ICPC
Rheumatoid/seropositive arthritis
1.8
6.8
108
606
Z02.7
ICD-10 Finland
Issue of medical certificate
1.6
6.8
177
1142
WYA10
NOMESCO Finland
First aid or other corresponding healthcare contact
1.5
6.7
200
1331
K90.8
ICD-10 Finland
Other intestinal malabsorption
16.7
6.7
10
6
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
1.6
6.7
183
1192
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
2.3
6.7
58
256
318
Kela drug reimbursment
Teriparatide
4.3
6.7
23
54
SGB10
NOMESCO Finland
Fiiling of rooth of tooth with one root channel
1.4
6.7
307
2229
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
1.4
6.7
303
2199
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
3.1
6.7
34
111
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.2
6.7
982
8378
SPAT1216
SPAT
Assessment of functional ability
1.3
6.7
570
4562
NFB20
NOMESCO Finland
Primary partial prosthetic replacement of hip joint using cement, other or unspecified
1.8
6.7
113
648
SGC00
NOMESCO Finland
Local medication of root channels of tooth
1.5
6.6
231
1592
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
2.9
6.6
36
123
D10
ICPC
Vomiting
1.8
6.6
99
543
E11.3
ICD-10 Finland
Type 2 diabetes mellitus, with ophthalmic complications
1.9
6.6
91
484
E05.0
ICD-10 Finland
Thyrotoxicosis with diffuse goitre
2.0
6.6
79
401
P03
ICPC
Feeling depressed
1.6
6.6
169
1084
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.2
6.6
914
7751
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.6
6.6
169
1087
SPAT1281
SPAT
Other administrative function
1.5
6.6
216
1472
K31.9
ICD-10 Finland
Disease of stomach and duodenum, unspecified
12.2
6.6
11
9
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.4
6.6
271
1933
K13.74
ICD-10 Finland
Lichen rubs planus in the mouth
2.7
6.5
40
147
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.3
6.5
643
5239
M79.2
ICD-10 Finland
Neuralgia and neuritis, unspecified
2.1
6.5
67
320
K83.0
ICD-10 Finland
Cholangitis
2.3
6.5
54
234
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
1.7
6.5
115
665
M14.6*E10.6
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic neuropathic
10.0
6.5
12
12
2448A
ICD-9 Finland
Acquired hypothyroidism, Other specified acquired hypothyroidism[HYPOTHYREOSIS POST THYREOIDITIDEM]
10.0
6.5
12
12
SPAT1229
SPAT
Assessment of need for aid
1.4
6.5
287
2072
306
Kela drug reimbursment
Erythropoietin and darbepoetin
4.8
6.5
20
42
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
1.9
6.5
88
465
Z98.8
ICD-10 Finland
Other specified postsurgical states
2.7
6.5
42
157
6480A
ICD-9 Finland
Other current conditions in the mother classifiable elsewhere but complicating pregnancy, childbirth and the puerperium, Diabetes mellitus
4.1
6.5
23
56
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.5
6.5
209
1419
E05.9
ICD-10 Finland
Thyrotoxicosis, unspecified
2.0
6.5
76
384
M81.4
ICD-10 Finland
Drug-induced osteoporosis
5.0
6.5
19
38
N18.0
ICD-10 Finland
End-stage renal disease
2.5
6.5
49
200
SPAT1284
SPAT
Extensive health certificate
1.9
6.5
82
426
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
1.9
6.5
84
440
O24.0
ICD-10 Finland
Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent
3.8
6.5
25
66
L13.0
ICD-10 Finland
Dermatitis herpetiformis
4.5
6.4
21
47
5608A
ICD-9 Finland
Intestinal obstruction without mention of hernia, Other specified intestinal obstruction[OBSTRUCTIO INTESTINALIS ,ADHESIONES INTRAABDOMINALE]
4.5
6.4
21
47
R4120
NOMESCO Finland
Occupational therapy
1.5
6.4
181
1189
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.3
6.4
506
4008
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.5
6.4
227
1571
R33
ICD-10 Finland
Retention of urine
1.4
6.4
303
2213
UJC12
NOMESCO Finland
Flexible oesophagoscopy
3.0
6.4
33
109
L40.0
ICD-10 Finland
Psoriasis vulgaris
1.7
6.4
114
666
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
3.6
6.4
26
72
D07AC13
ATC
mometasone; topical
1.2
6.4
876
7418
M81.9
ICD-10 Finland
Osteoporosis, unspecified
1.6
6.3
136
836
JWW96
NOMESCO Finland
Other reoperation in gastroenterological surgery
6.5
6.3
15
23
S29
ICPC
Skin symptom/complaint other
1.3
6.3
504
3996
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
1.5
6.3
230
1602
K29.6
ICD-10 Finland
Other gastritis
2.5
6.3
46
187
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
2.6
6.3
43
169
ZJX00
NOMESCO Finland
Double balloon technique in gastroenterological endoscopy
11.0
6.3
11
10
K04.4
ICD-10 Finland
Acute apical periodontitis of pulpal origin
1.5
6.3
199
1344
24200
ICD-8 Finland
Thyrotoxicosis with or without goitre, Cum struma diffusa et exophthalmo. Morbus Basedowi
9.3
6.3
12
13
M32.8
ICD-10 Finland
Other forms of systemic lupus erythematosus
9.3
6.3
12
13
JDC97
NOMESCO Finland
Laparoscopic partial gastrectomy with other reconstruction
18.0
6.3
9
5
1300
FHL
Esophagogastroduodenoscopy (also includes staining)
2.4
6.3
48
199
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
3.8
6.3
24
63
ND1AA
NOMESCO Finland
Wrist X-ray examination
1.6
6.3
164
1062
E31.08
ICD-10 Finland
Autoimmune polyglandular failure
+∞
6.2
6
*
28199
ICD-8 Finland
Other vitamin B12 deficiency anaemia, Other and unspecified deficiency anaemia
+∞
6.2
6
*
JD003
NOMESCO Finland
Adjuvant radiotherapy of gastric or duodenal tumor
+∞
6.2
6
*
JFA60
NOMESCO Finland
Stricturoplasty in small intestine
+∞
6.2
6
*
A10BB01
ATC
glibenclamide; oral
1.5
6.2
222
1539
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
3.3
6.2
28
84
E87.2
ICD-10 Finland
Acidosis
4.3
6.2
21
49
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.4
6.2
304
2235
B01AB10
ATC
tinzaparin; parenteral
1.5
6.2
208
1424
D99
ICPC
Disease digestive system other
2.8
6.2
36
128
K91.4
ICD-10 Finland
Colostomy and enterostomy malfunction
6.3
6.1
15
24
SGA04
NOMESCO Finland
Very demanding opening and dilatation of root canal of tooth
1.5
6.1
222
1542
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
5.3
6.1
17
32
ZX121
NOMESCO Finland
Central venous catheter
5.7
6.1
16
28
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
2.4
6.1
48
203
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
1.6
6.1
162
1051
JKB00
NOMESCO Finland
Incision of bile duct
4.6
6.1
19
41
WZA90
NOMESCO Finland
Other doctors statement
1.3
6.1
589
4789
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
1.9
6.1
77
401
N05AX08
ATC
risperidone; systemic
1.4
6.1
274
1989
S22
ICPC
Nail symptom/complaint
1.5
6.1
171
1126
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
2.0
6.1
70
351
K07
ICPC
Swollen ankles/oedema
1.6
6.1
151
967
XF402
NOMESCO Finland
ECG with work load test
1.4
6.0
349
2640
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.4
6.0
232
1632
R00.1
ICD-10 Finland
Bradycardia, unspecified
1.6
6.0
131
807
S18
ICPC
Laceration/cut
1.2
6.0
1341
11888
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
2.0
6.0
72
366

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
1998
9179
3.09
292.78
3.2
2.0
mg/l
3.2
2.9
5.14
1765
7637
(40768797) Stomach Pathology biopsy report
1145
4253
3.26
234.64
1.5
1.2
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
1290
5413
2.93
210.77
3.0
2.3
umol/l
11.7
12.8
6.55
1196
4947
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
2596
15434
2.58
209.42
3.1
2.0
pmol/l
81.1
93.6
26.52
1582
7892
(3004789) Transferrin [Mass/volume] in Serum or Plasma
1206
5009
2.91
199.44
2.9
2.3
g/l
2.4
2.3
6.85
1126
4581
(3001122) Ferritin [Mass/volume] in Serum or Plasma
2339
13481
2.51
198.00
4.5
2.5
ug/l
128.8
147.8
1.31
2167
12176
(3019309) Folate [Moles/volume] in Red Blood Cells
1600
7848
2.60
189.36
2.1
1.8
nmol/l
1135.5
1164.1
0.59
1258
5746
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
1118
4668
2.85
181.06
3.0
2.4
%
20.2
23.1
8.26
924
3903
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
1514
8124
2.29
138.46
2.3
1.7
pmol/l
15057828.3
27327431.4
0.50
1222
6532
(3027945) Reticulocytes/100 erythrocytes in Blood
967
4251
2.62
137.55
2.8
2.3
%
1.8
1.7
1.16
844
3684
(3021960) Folate [Moles/volume] in Serum or Plasma
1597
8978
2.20
128.38
1.9
1.5
nmol/l
20.8
20.4
0.50
1414
7585
(3003458) Phosphate [Moles/volume] in Serum or Plasma
947
4684
2.29
100.65
5.5
5.1
mmol/l
1.0
1.0
0.02
885
4277
(3023520) Reticulocytes [#/volume] in Blood
714
3172
2.48
96.48
2.7
2.4
e9/l
70.2
67.1
0.60
562
2388
(3024561) Albumin [Mass/volume] in Serum or Plasma
2305
15944
1.90
95.57
7.0
4.4
g/l
33.9
34.8
12.19
2156
14612
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
2064
14171
1.83
83.89
3.2
2.2
nmol/l
76.6
79.3
4.35
1878
12398
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
2533
18669
1.80
79.81
8.6
6.4
mmol/l
1.2
1.2
3.46
2145
15581
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
431
1640
2.80
78.99
1.9
1.7
g/l
1.5
1.5
0.64
357
1389
(3019069) Monocytes/100 leukocytes in Blood
2194
15571
1.79
77.90
7.4
5.9
%
8.9
8.8
0.24
2063
14373
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
678
3235
2.29
76.74
3.0
2.0
g/l
0.2
0.2
2.56
632
2984
(3002030) Lymphocytes/100 leukocytes in Blood
2221
15898
1.77
75.87
7.3
5.7
%
25.5
26.6
4.17
2079
14582
(3022096) Basophils/100 leukocytes in Blood
2130
15069
1.77
75.72
7.1
5.6
%
0.6
0.7
0.14
1993
13878
(3006504) Eosinophils/100 leukocytes in Blood
2177
15503
1.77
75.62
7.2
5.6
%
2.9
2.8
0.44
2038
14273
(3013005) Retinol [Moles/volume] in Serum or Plasma
85
86
10.05
74.66
2.6
1.3
umol/l
2.0
2.0
0.14
79
80
(3018010) Neutrophils/100 leukocytes in Blood
2184
15653
1.76
73.43
7.1
5.5
%
58.9
58.3
1.31
2044
14438
(3006315) Basophils [#/volume] in Blood
2275
16531
1.75
72.55
7.2
5.3
e9/l
0.0
0.0
1.54
1970
14052
(42870588) Differential panel, method unspecified - Blood
1708
11447
1.79
72.13
6.7
5.4
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
2308
16865
1.74
71.92
7.5
5.6
mmol/l
1.2
1.2
2.08
2098
15076
(3001604) Monocytes [#/volume] in Blood
2262
16438
1.74
71.87
7.2
5.3
e9/l
0.6
0.6
1.62
1960
13960
(3012095) Magnesium [Moles/volume] in Serum or Plasma
1016
5793
1.97
71.50
3.5
2.9
mmol/l
0.8
0.8
7.00
950
5314
(3013115) Eosinophils [#/volume] in Blood
2327
17084
1.74
70.94
7.3
5.5
e9/l
0.2
0.2
0.18
2040
14736
(3019198) Lymphocytes [#/volume] in Blood
2299
16867
1.73
69.85
7.2
5.4
e9/l
1.7
1.9
6.65
2032
14583
(3000570) Elastase.pancreatic [Mass/mass] in Stool
299
1002
3.12
68.67
1.6
1.4
ug/g
243.9
272.6
1.67
201
589
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
2434
18453
1.68
62.83
8.0
5.7
umol/l
12.3
12.1
0.26
2310
17425
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
1611
11057
1.71
59.67
3.1
2.4
u/l
59.8
58.9
0.26
1484
10122
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
752
4136
1.98
57.45
3.8
3.9
u/l
262.8
251.0
0.51
706
3876
(3023368) Bacteria identified in Blood by Culture
1566
10789
1.69
56.44
4.9
4.1
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
2500
19443
1.63
55.40
10.9
8.4
e9/l
4.2
4.3
0.82
2209
16792
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
1005
6146
1.81
55.08
1.4
1.2
u/ml
2.4
1.5
0.77
222
1578
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
712
3936
1.96
53.28
4.8
3.8
ug/l
14.1
23.5
0.99
613
3235
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
76
105
7.34
52.07
2.9
1.2
umol/l
28.1
30.0
0.61
71
100
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
541
2741
2.10
51.48
1.9
1.6
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
881
5348
1.80
48.79
1.5
1.5
g/l
2.7
2.5
0.89
482
3103
(3048689) Calprotectin [Mass/mass] in Stool
614
3324
1.98
48.51
3.9
2.0
ug/g
217.7
144.1
3.65
518
2565
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
318
1327
2.50
47.83
4.4
3.2
u/ml
1203.3
4393.1
0.78
275
1125
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
669
3777
1.90
46.54
3.5
2.5
umol/l
8.2
9.4
1.10
591
3290
(3022145) Colonoscopy Study observation
624
3466
1.93
45.53
1.5
1.3
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1454
10254
1.61
45.53
3.9
3.0
u/l
36.8
37.9
0.14
1379
9668
(3018418) pH of Serum or Plasma
1542
11086
1.59
44.25
5.1
3.7
ph
7.4
7.4
1.55
279
2059
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
3174
26920
1.59
42.90
10.8
7.2
u/l
88.1
80.7
9.85
3009
25081
(3032080) INR in Blood by Coagulation assay
2019
15527
1.54
42.46
10.6
10.4
inr
1.3
1.3
1.34
543
4268
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
224
840
2.75
41.77
1.7
1.5
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
527
2880
1.94
40.09
4.2
3.5
ng/l
106.9
90.4
2.59
435
2407
(3036481) Cortisol [Moles/volume] in Serum or Plasma
525
2883
1.93
39.32
2.0
2.1
nmol/l
380.5
378.5
0.07
472
2607
(3020779) Urea [Moles/volume] in Serum or Plasma
566
3266
1.84
36.19
6.8
6.2
mmol/l
11.0
10.9
0.09
535
3065
(3044640) Blood type and Crossmatch panel - Blood
1492
11084
1.51
34.96
3.3
2.4
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
2558
21168
1.47
34.83
6.4
4.5
mmol/l
7.2
6.8
8.53
2442
19841
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
194
750
2.66
34.07
3.9
3.0
u/ml
256.8
944.0
1.01
176
688
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1981
15933
1.43
29.36
5.0
4.0
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
1559
12056
1.44
28.36
4.1
3.4
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
1615
12636
1.43
27.30
3.7
3.3
mmol/l
2.3
2.4
10.29
1409
10797
(3002032) Base excess in Venous blood by calculation
570
3580
1.68
26.62
5.2
3.3
mmol/l
1.5
2.0
2.16
452
2867
(3033658) Prothrombin time (PT) actual/Normal
1185
8791
1.47
26.44
5.0
3.7
%
84.9
86.3
1.06
1163
8554
(3013707) Erythrocyte sedimentation rate by Westergren method
2900
25194
1.41
26.42
5.2
4.0
mm/h
16.2
13.7
10.88
2696
22989
(36660697) Celiac disease serology panel - Serum
384
2172
1.84
25.86
1.2
1.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
243
1185
2.11
25.16
1.4
1.2
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
520
3234
1.69
25.14
2.3
2.5
g/l
65.6
66.1
0.70
468
2896
(3021447) Carbon dioxide [Partial pressure] in Venous blood
565
3595
1.65
25.01
5.2
3.3
kpa
5.8
5.8
0.73
551
3473
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
317
1707
1.92
24.86
6.6
3.4
mmol/l
23.6
24.3
2.66
295
1508
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
136
520
2.66
24.47
1.3
1.2
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
445
2685
1.73
24.01
2.1
2.4
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
497
3125
1.66
22.95
3.6
2.3
u/l
36.1
53.5
0.56
428
2642
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
896
6444
1.49
22.92
2.1
1.8
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
595
3914
1.60
22.90
1.4
1.3
titre
624.5
503.4
0.73
160
866
(3042936) Bacteria identified in Isolate by Culture
721
4967
1.54
22.64
2.3
1.9
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
695
4754
1.54
22.53
8.5
6.1
mmol/l
104.5
104.3
0.60
677
4631
(3005719) IgG [Mass/volume] in Serum or Plasma
383
2256
1.76
22.45
2.9
2.7
g/l
10.7
10.6
0.05
346
2032
(3000991) Gas panel - Venous blood
486
3057
1.66
22.39
9.8
7.0
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
97
325
3.03
22.31
1.3
1.1
u/l
53.4
58.3
0.48
65
222
(3017143) Hepatitis C virus Ab [Presence] in Serum
434
2657
1.70
22.15
1.6
1.5
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
2722
23730
1.36
22.11
6.2
5.0
e6/l
4760.4
2198.4
0.76
51
391
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
110
399
2.80
21.94
3.7
3.2
nmol/l
7.1
19.2
0.42
105
388
(3003396) Base excess in Arterial blood by calculation
650
4418
1.55
21.62
7.2
6.3
mmol/l
0.9
1.1
0.76
483
3398
(3037467) Urinalysis macro (dipstick) panel - Urine
2755
24115
1.36
21.49
5.8
4.6
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
592
3967
1.57
20.94
7.5
6.6
%
94.9
95.4
0.67
562
3799
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2330
19949
1.34
20.65
3.7
3.0
u/l
59.0
52.6
1.58
2156
18116
(3014111) Lactate [Moles/volume] in Serum or Plasma
507
3293
1.61
20.47
8.0
5.9
mmol/l
1.4
1.4
0.65
485
3149
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
2843
25094
1.35
20.46
5.4
4.0
pmol/l
15.2
15.0
2.59
2568
22347
(3006653) Thiamine [Moles/volume] in Blood
60
157
3.86
20.31
1.4
1.2
nmol/l
124.5
138.2
1.54
60
157
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
1419
11287
1.37
20.26
2.2
2.1
u/l
193.4
229.0
0.64
1333
10480
(3007853) Bacteria identified in Skin by Aerobe culture
594
4039
1.54
19.61
2.1
1.7
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
467
3005
1.62
19.56
4.3
2.8
kpa
4.4
4.5
0.12
453
2890
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
334
1968
1.75
19.52
2.7
2.4
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
639
4432
1.51
19.21
7.3
6.3
kpa
5.0
5.1
0.38
599
4191
(40760892) CBC W Ordered Manual Differential panel - Blood
906
6731
1.43
19.15
5.6
4.3
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
308
1785
1.78
19.06
1.9
1.8
g/l
1.4
1.4
0.05
272
1598
(3027801) Oxygen [Partial pressure] in Arterial blood
638
4431
1.51
19.05
7.3
6.3
kpa
12.2
12.0
0.34
601
4188
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
33
56
5.93
18.68
3.7
3.0
mg/l
6.7
6.4
0.11
27
47
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
1098
8467
1.39
18.67
3.0
2.3
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
386
2399
1.66
18.53
3.8
3.6
kpa
5.1
5.2
0.93
349
2188
(46235355) HIV 1 and 2 tests - Meaningful Use set
523
3502
1.56
18.44
1.7
1.6
—
—
—
0
0
(3009343) pH of Capillary blood
382
2373
1.67
18.37
3.7
3.6
ph
7.4
7.4
0.17
48
285
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
464
3027
1.59
18.32
1.6
1.5
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
437
2812
1.61
18.27
4.1
3.9
%
1.0
1.0
0.03
158
812
(3002582) Erythrocytes [#/volume] in Urine
1405
11300
1.35
18.26
4.0
3.3
e6/l
93.7
100.9
0.08
1121
8759
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
332
1991
1.72
18.21
9.9
8.8
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
175
854
2.09
18.13
1.8
1.7
—
—
—
0
0
(3026782) Osmolality of Urine
988
7529
1.40
17.92
3.4
2.8
mosm/kgh2o
535.1
548.2
1.23
840
6383
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
369
2289
1.67
17.84
3.6
3.5
mmol/l
1.4
1.9
1.63
248
1649
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
177
873
2.07
17.83
1.6
1.6
iu/ml
0.4
16.2
1.16
37
201
(3018677) aPTT in Platelet poor plasma by Coagulation assay
780
5708
1.44
17.76
2.0
1.9
s
30.2
30.1
0.19
759
5524
(3023183) Ammonium ion [Moles/volume] in Plasma
146
672
2.21
17.56
2.3
2.2
umol/l
33.1
33.3
0.02
113
545
(40758558) Short blood count panel - Blood
1106
8619
1.37
17.45
8.2
6.3
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
531
3617
1.53
17.28
7.9
7.0
g/l
114.3
120.8
11.32
514
3479
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
265
1515
1.80
17.17
1.9
2.4
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
265
1515
1.80
17.17
1.9
2.4
g/l
7.4
7.4
0.12
192
1107
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
264
1512
1.79
17.00
1.9
2.4
g/l
3.7
3.8
0.15
187
1062
(40760888) Immunoglobulin light chains.free panel - Serum
184
943
1.99
16.69
2.5
3.4
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
224
1227
1.87
16.67
2.6
3.3
ratio
5.9
1.8
0.65
13
91
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
157
760
2.10
16.64
1.6
1.3
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
228
1258
1.85
16.58
2.6
3.3
mg/l
37.5
62.0
1.37
188
1035
(3009508) Creatinine [Moles/volume] in Urine
1357
10983
1.33
16.56
3.6
3.1
mmol/l
6.8
7.1
2.18
1132
9068
(3034860) Kappa light chains.free [Mass/volume] in Serum
228
1261
1.85
16.46
2.6
3.3
mg/l
58.2
64.8
0.33
189
1034
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
249
1418
1.80
16.35
2.0
2.4
g/l
10.5
10.4
0.24
207
1192
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
364
2301
1.63
16.32
1.5
1.5
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
244
1396
1.79
15.77
2.0
2.4
g/l
3.2
3.1
0.64
191
1087
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
59
182
3.27
15.68
1.3
1.1
u/l
91.0
85.9
0.18
51
158
(3028717) Thiamine [Mass/volume] in Blood
23
32
7.22
15.66
1.2
1.2
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
1724
14521
1.30
15.54
13.1
9.6
e9/l
0.0
0.0
0.94
1393
11775
(3020682) Albumin/Creatinine [Ratio] in Urine
1388
11351
1.32
15.54
4.5
3.9
mg/mmol
11.4
8.8
1.10
913
7088
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
376
2427
1.60
15.47
1.8
1.7
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
391
2548
1.58
15.45
4.0
3.7
%
0.5
0.6
0.31
107
569
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
57
174
3.30
15.41
1.3
1.1
u/l
25.5
21.6
0.28
49
147
(3020961) Endomysium IgA Ab [Titer] in Serum
219
1229
1.82
15.10
1.1
1.1
titre
520.0
211.3
—
5
27
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
147
721
2.07
15.08
1.1
1.1
u/ml
11.1
7.7
0.24
15
67
(3021440) Promyelocytes/100 leukocytes in Blood
406
2684
1.56
15.07
4.1
3.9
%
0.1
0.1
0.07
144
757
(3000850) Epithelial cells [#/volume] in Urine
1020
8007
1.35
15.03
3.0
2.6
e6/l
5.1
5.3
0.16
906
6998
(3035350) Ketones [Presence] in Urine by Test strip
1960
16837
1.29
15.02
4.7
3.9
estimate
0.0
0.0
0.00
367
3080
(3018095) Leukocytes [#/volume] in Urine
1553
12944
1.30
15.01
4.8
3.8
e6/l
138.3
120.1
0.30
1173
9373
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
171
889
1.96
14.92
1.8
1.4
iu/ml
14.8
15.4
0.03
11
20
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
201
1104
1.86
14.85
1.8
2.3
g/l
0.0
0.1
0.80
180
1005
(3022217) INR in Platelet poor plasma by Coagulation assay
759
5691
1.40
14.84
24.5
28.5
inr
1.4
1.5
0.48
106
768
(36304419) Bacteria [Presence] in Urine
1228
9927
1.32
14.78
3.8
3.2
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
960
7483
1.36
14.77
4.6
3.9
ng/l
315.4
508.0
0.63
796
6283
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
60
195
3.10
14.66
1.8
1.8
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
223
1271
1.79
14.62
2.0
2.4
g/l
0.5
1.0
1.83
191
1076
(3012516) Albumin [Mass/volume] in Urine
1314
10742
1.31
14.55
3.7
3.2
mg/l
432.9
305.1
0.46
884
6738
(3000494) Fungus identified in Specimen by Culture
536
3786
1.47
14.52
1.5
1.4
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
189
1029
1.87
14.37
1.9
2.4
g/l
0.0
0.0
0.50
168
936
(3009261) Glucose [Presence] in Urine by Test strip
1978
17076
1.28
14.35
4.7
4.0
estimate
0.0
0.0
0.80
355
3041
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
615
4470
1.43
14.31
2.1
1.7
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
149
751
2.02
14.21
1.3
1.2
titre
121.1
85.0
—
9
42
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
186
1014
1.87
14.09
1.9
2.4
g/l
0.0
0.0
0.00
167
933
(3024928) Oxygen saturation in Venous blood
149
759
2.00
13.80
4.1
2.6
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
1456
12152
1.29
13.60
3.2
3.0
ng/l
2199.3
1763.2
2.59
1286
10489
(3025941) Bacteria identified in Stool by Culture
277
1712
1.66
13.57
1.4
1.3
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
1947
16856
1.27
13.52
6.4
5.3
estimate
0.0
0.0
0.50
372
3082
(3009445) Proteinase 3 Ab [Units/volume] in Serum
238
1427
1.70
13.08
1.5
1.6
u/ml
16.4
22.5
—
9
39
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
606
4462
1.41
13.05
2.1
1.7
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
202
1157
1.78
13.05
5.1
6.0
mmol/l
1.4
1.3
0.88
183
1021
(3030467) Casts [#/volume] in Urine by Automated count
1252
10291
1.30
13.04
3.9
3.2
e6/l
0.6
0.5
0.30
976
7861
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
285
1795
1.63
12.97
3.1
3.2
pmol/l
4.1
4.4
6.22
249
1554
(3025159) Blasts/100 leukocytes in Blood
371
2488
1.53
12.89
4.3
3.9
%
0.1
0.4
0.75
120
629
(3024980) IgG subclass 4 [Mass/volume] in Serum
93
408
2.31
12.65
1.8
1.6
g/l
0.8
0.9
0.49
78
305
(3003181) Sodium [Moles/volume] in Urine
135
687
1.99
12.58
1.8
1.3
mmol/l
60.3
62.0
0.21
115
553
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
202
1172
1.76
12.50
1.8
2.2
g/l
36.5
37.4
1.28
174
988
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
763
5878
1.36
12.45
3.7
3.0
e6/l
3.4
2.4
1.32
435
3272
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
3565
33369
1.31
12.42
24.5
15.9
mg/l
28.2
26.0
2.92
3097
27138
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
1699
14588
1.26
12.28
4.5
4.0
ng/l
51.9
72.0
0.74
1325
10881
(3010370) Gastrin [Moles/volume] in Serum or Plasma
23
42
5.50
12.10
1.8
1.6
pmol/l
223.1
23.8
2.78
18
33
(3019225) pH of Specimen
527
3838
1.42
12.04
5.4
4.4
—
—
—
0
0
(3022313) Gas panel - Capillary blood
268
1695
1.62
12.00
4.0
3.6
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
34
88
3.88
11.79
1.2
1.2
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
914
7298
1.32
11.60
3.9
3.0
mmol/l
2.5
2.5
0.65
800
6360
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
183
1061
1.75
11.38
1.6
1.6
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
325
2178
1.53
11.32
3.2
3.2
e9/l
4.2
4.2
0.01
250
1583
(3026493) Urate [Moles/volume] in Serum or Plasma
1113
9165
1.28
11.13
3.1
2.7
umol/l
2624.9
6198.5
3.30
937
7735
(3015736) pH of Urine
1541
13197
1.25
11.09
4.3
3.7
—
5.8
—
0
9
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
18
28
6.45
11.08
1.4
1.0
nmol/l
8.7
343484.6
0.48
13
23
(3000093) Morphology [Interpretation] in Blood Narrative
76
325
2.36
11.01
1.2
1.1
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
151
839
1.83
10.84
2.6
2.2
g/l
3.5
3.7
0.63
139
801
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
171
988
1.76
10.78
1.9
1.7
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
346
2386
1.49
10.52
4.3
3.1
g/l
118.1
128.3
12.40
335
2332
(3011985) Renin [Units/volume] in Plasma
88
409
2.17
10.49
2.0
1.3
mu/l
111.2
49.1
0.77
76
361
(3015235) Bicarbonate [Moles/volume] in Capillary blood
175
1026
1.73
10.49
2.9
3.1
mmol/l
23.8
25.0
3.05
152
894
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
294
1965
1.53
10.38
9.9
8.0
mmol/l
23.8
24.3
2.01
273
1807
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
904
7308
1.30
10.34
1.7
1.6
mg/l
1.7
1.4
1.14
713
5663
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
48
169
2.86
10.30
1.4
1.3
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
49
176
2.80
10.15
1.7
1.5
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
49
176
2.80
10.15
1.7
1.5
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
252
1637
1.57
10.11
4.9
4.9
%
1.6
1.6
0.37
241
1536
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
118
620
1.93
10.10
2.0
1.6
nmol/l
0.7
0.8
0.22
103
508
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
496
3687
1.39
10.01
3.3
2.9
ng/l
285.5
241.1
0.87
453
3350
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
48
172
2.81
9.99
1.4
1.3
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
60
241
2.51
9.98
1.6
1.1
mmol/l
30.8
34.3
0.45
53
196
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
115
602
1.93
9.96
3.6
3.6
%
59.8
58.4
0.50
115
602
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
149
847
1.78
9.95
1.8
1.5
g/l
0.2
0.2
1.63
139
797
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
3252
30368
1.25
9.88
6.6
4.8
mu/l
2.0
2.1
0.31
2962
27192
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
182
1097
1.69
9.88
1.6
1.6
titre
275.7
282.8
0.02
14
57
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
12
13
9.25
9.87
2.2
1.6
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
15
9
16.72
9.86
1.1
1.0
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
36
110
3.29
9.83
2.3
2.3
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
50
185
2.72
9.80
1.0
1.1
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
224
1427
1.60
9.78
4.2
3.8
mmol/l
24.4
24.8
1.09
203
1281
(3021901) Oxygen saturation in Capillary blood
135
750
1.82
9.74
2.9
2.8
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
152
878
1.76
9.63
3.1
2.9
kpa
8.0
7.8
0.70
144
809
(3019060) Gas panel - Arterial blood
368
2614
1.44
9.61
4.4
4.5
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
785
6284
1.30
9.60
3.4
2.8
e6/l
1.5
1.2
0.95
454
3641
(3008152) Bicarbonate [Moles/volume] in Arterial blood
354
2497
1.45
9.59
6.2
6.3
mmol/l
24.3
24.6
0.72
332
2326
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
151
877
1.75
9.39
1.8
1.5
g/l
1.1
1.2
0.48
142
826
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
249
1643
1.55
9.34
1.9
1.9
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
246
1619
1.55
9.34
4.9
5.0
%
0.9
0.9
0.03
236
1519
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
90
443
2.05
9.29
1.7
1.4
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
46
168
2.76
9.26
1.2
1.1
u/l
80.0
86.6
0.24
36
125
(3037756) Immunofixation for Serum or Plasma
147
853
1.75
9.18
1.6
1.5
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
251
1666
1.54
9.17
1.4
1.3
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
46
169
2.74
9.16
1.2
1.1
u/l
20.4
29.8
0.99
37
123
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
88
432
2.06
9.16
1.3
1.2
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
135
768
1.78
9.03
1.4
1.2
u/ml
4.7
6.9
0.40
25
137
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
213
1369
1.58
8.98
3.0
2.6
u/ml
0.3
0.3
0.04
117
783
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
90
449
2.02
8.97
1.7
1.4
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
52
206
2.54
8.94
1.5
1.5
u/l
3.4
7.9
1.38
23
95
(3035637) Corticotropin [Mass/volume] in Plasma
74
343
2.18
8.94
1.4
1.5
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
141
816
1.75
8.90
1.4
1.2
u/ml
12.8
41.8
1.49
12
53
(3024522) Salmonella sp identified in Specimen by Organism specific culture
89
447
2.01
8.72
1.7
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
88
441
2.01
8.68
1.7
1.4
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
118
653
1.83
8.66
1.4
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
88
442
2.01
8.63
1.7
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
88
442
2.01
8.63
1.7
1.4
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
242
1616
1.53
8.62
1.9
1.9
ug/l
3.9
2.2
0.88
217
1381
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
50
199
2.53
8.53
1.3
1.1
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
60
260
2.32
8.52
1.4
1.3
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
105
564
1.88
8.47
4.2
4.5
iu/ml
1635.8
3529.4
0.25
19
75
(3006184) Hemoglobin [Mass/volume] in Capillary blood
145
860
1.71
8.41
2.2
2.1
g/l
121.3
129.0
2.53
106
620
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
263
1810
1.48
8.12
4.2
2.4
%
0.7
0.6
1.15
254
1731
(3042111) Morphology [Interpretation] in Bone marrow Narrative
115
646
1.80
8.07
1.5
1.5
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
226
1511
1.52
8.02
1.9
1.8
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
650
5198
1.29
7.92
1.3
1.3
iu/ml
33.5
36.4
0.19
183
1638
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
112
629
1.80
7.87
1.2
1.2
u/ml
10.3
3.8
0.33
13
49
(1616796) Gas panel - Central venous blood
142
854
1.68
7.85
3.9
3.5
—
—
—
0
0
(4035726)
410
3074
1.37
7.83
1.5
1.3
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
193
1255
1.56
7.78
3.0
3.0
g/l
0.3
0.3
0.13
88
478
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
16
32
5.01
7.65
1.0
1.1
ug/l
87.4
75.2
—
10
23
(3006270) Folate [Moles/volume] in Blood
73
361
2.04
7.52
1.3
1.2
nmol/l
347.4
331.4
0.18
67
291
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
57
256
2.24
7.50
1.4
1.3
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
371
2757
1.38
7.49
1.7
1.7
%
1.5
1.5
0.00
316
2361
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
128
759
1.71
7.47
1.4
1.2
u/ml
3.5
3.6
0.03
19
72
(3044927) Protein electrophoresis panel - Urine
80
411
1.96
7.42
1.2
1.2
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
143
881
1.64
7.24
2.3
2.3
ug/min
80.7
104.7
0.44
87
526
(3004616) Nuclear Ab [Presence] in Serum
76
387
1.98
7.24
1.3
1.2
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
102
574
1.79
7.16
1.4
1.2
u/ml
47.2
40.7
0.14
14
66
(3039000) Anion gap in Blood
138
846
1.65
7.13
6.0
6.8
mmol/l
11.3
11.2
0.20
128
752
(3019550) Sodium [Moles/volume] in Serum or Plasma
3650
34881
1.23
7.10
28.2
18.8
mmol/l
139.3
139.6
8.80
3553
33858
(3018572) Chloride [Moles/volume] in Blood
138
847
1.65
7.10
6.0
6.8
mmol/l
105.1
105.1
0.02
128
753
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
133
809
1.66
7.08
2.7
2.7
mg/l
1.8
1.7
0.85
121
714
(3029937) Albumin [Presence] in Urine by Test strip
1084
9306
1.22
6.98
5.2
4.3
estimate
0.0
0.0
1.08
343
2947
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
50
220
2.29
6.93
1.2
1.2
titre
92.5
117.9
0.27
12
38
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
48
210
2.30
6.75
1.1
1.0
mg/l
294.8
289.4
0.16
40
182
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
195
1314
1.51
6.72
1.5
1.8
u/l
35.6
38.7
1.51
159
1132
(3000012) Reticulocyte production index
46
198
2.34
6.71
1.8
1.4
—
—
—
0
0
(21494434) Karyotype in Bone marrow
65
322
2.03
6.71
1.1
1.2
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
408
3131
1.33
6.70
4.4
3.5
mmol/l
1.2
1.2
3.54
355
2693
(3023103) Potassium [Moles/volume] in Serum or Plasma
3652
34956
1.22
6.70
28.5
18.9
mmol/l
4.0
4.0
0.51
3550
33875
(1761868) Lipid panel - Serum or Plasma
820
9696
0.81
6.64
3.3
3.1
—
—
—
0
0
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
11
9
12.25
6.57
1.2
1.1
nmol/l
369.0
303.0
—
11
9
(3052592) Norovirus Ag [Presence] in Stool
25
79
3.18
6.55
1.6
1.3
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
136
850
1.62
6.54
2.3
2.0
%
89.5
90.2
0.12
129
800
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
127
781
1.64
6.51
2.8
2.2
%
192.5
197.8
0.26
118
745
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
320
2377
1.37
6.50
10.0
7.7
%
0.7
0.7
0.35
315
2358
(3004809) Band form neutrophils/100 leukocytes in Blood
101
584
1.75
6.50
3.0
3.6
%
1.8
1.5
0.24
76
433
(3014765) Yersinia sp identified in Stool by Organism specific culture
149
954
1.58
6.48
1.3
1.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
1025
8809
1.21
6.47
4.6
3.6
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
148
947
1.58
6.46
1.3
1.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
249
1775
1.43
6.44
1.2
1.2
iu/ml
221.2
135.0
1.98
97
648
(3030981) Hyaline casts [#/volume] in Urine by Automated count
282
2059
1.39
6.37
3.6
2.8
e6/l
0.3
0.3
0.60
276
2012
(3019150) Specific gravity of Urine by Refractometry
896
7610
1.22
6.36
5.2
4.5
kg/l
1.0
1.0
0.13
154
1189
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
320
2388
1.37
6.32
9.9
7.6
%
1.2
1.3
3.00
313
2370
(42529406) Shigella sp [Presence] in Stool by Culture
149
960
1.57
6.32
1.3
1.2
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
32
120
2.68
6.23
1.8
2.2
umol/l
47.9
141.4
2.09
23
71
(3017704) Immunofixation for Urine
48
218
2.21
6.21
1.7
1.4
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
34
132
2.59
6.19
3.5
2.9
mg/l
93.8
69.6
0.53
29
90
(40768441) Liver Pathology biopsy report
44
194
2.28
6.11
1.3
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
107
645
1.67
5.96
1.2
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
283
2092
1.38
5.95
1.1
1.2
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
34
135
2.53
5.93
1.0
1.0
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
42
184
2.29
5.93
1.1
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
42
184
2.29
5.93
1.1
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
42
184
2.29
5.93
1.1
1.1
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
70
375
1.88
5.82
1.1
1.1
g/l
1.5
1.5
0.04
62
333
(3052851) Hemolysis interference index of Serum or Plasma
167
1126
1.50
5.79
4.4
3.3
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
50
238
2.11
5.78
1.1
1.2
—
—
—
0
0
(3036489) Thrombin time
167
1127
1.50
5.77
2.2
1.8
s
22.3
21.5
0.47
156
1011
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
23
75
3.08
5.76
1.0
1.2
pmol/l
258.4
268.9
0.05
12
55
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
42
187
2.26
5.72
1.1
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
42
187
2.26
5.72
1.1
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
42
187
2.26
5.72
1.1
1.1
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
19
55
3.46
5.72
1.2
1.5
ng/l
121.6
129.0
0.09
19
55
(3009871) Measles virus Ab [Titer] in Serum
20
61
3.29
5.57
1.8
1.6
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
74
410
1.82
5.55
1.2
1.3
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
80
454
1.78
5.55
1.0
1.0
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
40
177
2.27
5.54
1.9
1.4
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
1449
12988
1.17
5.50
5.2
4.3
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
81
465
1.76
5.41
5.5
5.9
mg/l
12.1
12.2
0.05
70
422
(3009542) Hematocrit [Volume Fraction] of Blood
3053
28950
1.16
5.39
26.8
17.1
%
36.7
38.6
16.14
1858
18571
(3039162) Centromere protein B Ab [Units/volume] in Serum
66
359
1.85
5.27
1.3
1.2
u/ml
9.3
52.2
—
6
22
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
16
44
3.65
5.20
1.8
1.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
1519
13714
1.16
5.18
2.3
2.2
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
78
451
1.74
5.11
1.3
1.3
nmol/l
0.5
0.3
—
7
28
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
59
313
1.90
5.10
1.4
1.2
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
79
459
1.73
5.09
1.8
1.4
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
264
1985
1.35
5.02
4.6
3.2
mmol/l
24.6
25.2
1.87
256
1930
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
60
322
1.87
5.02
1.1
1.1
u/ml
3.5
2.4
0.30
16
115
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
24
88
2.74
4.93
2.0
1.5
ug/l
0.4
0.4
0.32
16
51
(21494890) Protein electrophoresis panel - 24 hour Urine
68
384
1.78
4.85
1.7
2.0
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
77
452
1.72
4.80
7.8
6.2
mmol/l
8.0
7.5
0.40
59
373
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
122
804
1.53
4.78
1.6
1.9
mg/l
14.1
12.4
0.41
106
737
(3016650) Hepatitis A virus Ab [Presence] in Serum
74
431
1.73
4.75
1.0
1.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
129
863
1.51
4.71
1.7
1.5
—
—
—
0
0
(3013512) EKG study
1224
10944
1.16
4.66
4.7
4.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
133
899
1.49
4.63
1.9
1.7
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
3530
33988
1.17
4.62
23.7
15.1
—
—
—
0
0
(3011648) Oxygen content in Venous blood
52
274
1.91
4.62
3.3
2.0
%
9.8
10.9
0.91
52
274
(3004716) Salmonella sp identified in Stool by Organism specific culture
187
1350
1.40
4.60
1.4
1.3
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
55
297
1.86
4.55
1.5
1.3
nmol/l
1.1
1.5
1.60
47
266
(3019977) pH of Arterial blood
44
220
2.01
4.54
2.7
2.4
ph
7.4
7.4
0.71
14
78
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
106
686
1.56
4.52
1.4
1.6
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
55
298
1.86
4.50
1.3
1.5
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
46
238
1.94
4.33
1.0
1.0
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
54
295
1.84
4.32
1.1
1.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
57
317
1.81
4.31
1.6
1.3
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
182
1324
1.39
4.30
2.8
2.6
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
38
184
2.07
4.29
2.2
1.9
e6/l
627.1
660.2
0.11
20
80
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
472
3910
1.23
4.23
4.3
3.6
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
75
455
1.66
4.19
1.2
1.1
iu/ml
122.1
83.6
0.35
13
88
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
66
387
1.72
4.18
1.3
1.3
pmol/l
485.8
272.9
0.44
44
291
(3010421) pH of Blood
142
996
1.44
4.14
4.7
4.0
ph
7.4
7.4
0.74
122
831
(21494815) CD4 cells/100 lymphocytes in Specimen
43
222
1.95
4.09
1.8
2.0
%
45.9
45.5
—
8
22
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
37
181
2.05
4.09
2.1
3.1
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
2793
26549
1.13
4.07
30.8
19.2
%
14.5
13.8
66.21
2736
25856
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
15
47
3.20
4.05
2.5
2.3
—
—
—
0
0
(4198724)
15
47
3.20
4.05
1.7
1.4
—
—
—
0
0
(3012501) Base excess in Blood by calculation
124
852
1.47
4.03
4.9
4.1
mmol/l
2.6
2.6
0.06
88
589
(3000764) Benzodiazepines [Presence] in Urine
67
399
1.69
4.03
1.8
1.4
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
925
8179
1.16
4.01
4.5
3.9
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
48
260
1.85
3.97
1.1
1.4
g/l
7.1
6.9
0.15
38
181
(3024139) IgG subclass 3 [Mass/volume] in Serum
48
260
1.85
3.97
1.1
1.4
g/l
0.4
0.4
0.20
38
181
(3028192) IgG subclass 2 [Mass/volume] in Serum
48
260
1.85
3.97
1.1
1.4
g/l
3.5
2.9
1.12
38
181
(3022621) pH of Urine by Test strip
309
2459
1.28
3.96
4.0
3.3
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
51
283
1.81
3.92
1.1
1.1
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
49
269
1.83
3.90
2.3
2.1
e9/l
0.9
1.0
0.33
26
164
(3048879) Bone marrow aspiration report
25
106
2.37
3.89
1.4
1.4
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
3210
30824
1.14
3.88
7.5
6.2
mmol/mol
42.2
40.6
12.50
2936
27987
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
121
835
1.46
3.86
1.8
1.5
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
71
435
1.64
3.85
1.3
1.2
u/ml
326.9
271.9
0.84
41
262
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
575
4903
1.20
3.85
1.3
1.2
u/ml
20.0
12.9
0.90
197
1803
(3015171) Extractable nuclear Ab [Units/volume] in Serum
159
1154
1.39
3.85
1.2
1.2
u/ml
2.5
1.0
0.36
12
111
(3000034) Microalbumin [Mass/volume] in Urine
56
322
1.75
3.83
3.0
3.0
mg/l
34.3
34.9
0.01
40
243
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
37
186
2.00
3.82
2.5
2.5
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
63
375
1.69
3.81
1.8
1.4
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
15
49
3.07
3.80
4.4
6.4
—
—
—
0
0
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
22
89
2.48
3.79
1.4
1.2
nmol/l
144.5
128.5
0.12
17
65
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
124
864
1.45
3.78
1.4
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
124
864
1.45
3.78
1.4
1.3
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
120
832
1.45
3.75
2.9
2.4
%
15.7
16.0
0.31
68
421
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
126
1771
0.70
3.74
1.7
1.8
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
75
470
1.61
3.73
1.3
1.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
60
355
1.70
3.72
1.8
1.5
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
66
401
1.66
3.71
1.8
1.4
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
3606
34938
1.15
3.69
15.0
10.6
u/l
23.5
25.0
3.65
3474
33340
(3027456) Digoxin [Moles/volume] in Serum or Plasma
139
994
1.41
3.68
3.2
3.2
nmol/l
0.9
0.8
0.59
96
761
(3028300) Cannabinoids [Presence] in Urine
66
402
1.65
3.68
1.8
1.4
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
57
335
1.71
3.63
1.8
1.5
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
60
360
1.68
3.55
3.5
3.0
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
64
391
1.65
3.54
1.8
1.4
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
25
111
2.26
3.54
1.3
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
36
185
1.95
3.52
1.4
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
36
185
1.95
3.52
1.4
1.3
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
10
26
3.85
3.52
1.0
1.1
—
—
—
0
0
(4062490)
47
264
1.79
3.51
1.1
1.4
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
187
1416
1.33
3.49
3.8
3.5
mmol/l
1.5
1.4
0.30
181
1390
(3011288) Drugs identified in Urine by Screen method
46
257
1.80
3.49
2.2
1.7
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
11
31
3.55
3.48
1.4
1.3
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1825
17013
1.12
3.47
2.8
2.5
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
63
387
1.64
3.42
3.1
4.1
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
79
513
1.55
3.41
1.6
1.3
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
77
1165
0.66
3.40
1.5
1.5
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
90
602
1.50
3.40
1.3
1.2
u/l
101.1
38.4
0.90
81
516
(3033705) Calcium.ionized [Moles/volume] in Venous blood
84
554
1.53
3.39
2.9
2.4
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
49
282
1.75
3.38
2.2
1.3
iu/ml
48.8
28.5
—
6
12
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
20
82
2.45
3.37
2.5
1.9
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
11
32
3.44
3.33
1.1
1.0
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
86
573
1.51
3.32
1.9
1.5
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
14
48
2.92
3.29
2.6
2.3
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
64
400
1.61
3.26
1.5
1.5
%
57.0
61.9
0.45
43
251
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
89
602
1.49
3.20
3.6
2.8
—
—
—
0
0
(3016750) Collection duration of Urine
36
193
1.87
3.14
1.7
1.9
min
511.8
487.0
0.76
25
137
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
12
39
3.08
3.08
6.5
15.2
mmol/l
4.1
5.5
1.39
12
39
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
31
159
1.96
3.08
1.8
1.2
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
8
16
5.01
3.05
1.7
1.3
umol/24h
542.8
352.4
—
8
16
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
21
93
2.26
3.02
1.2
1.1
miu/ml
1623.9
1720.0
0.14
21
93
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
168
1284
1.32
2.99
1.9
2.1
ug/l
433.0
708.0
0.80
158
1207
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
91
628
1.46
2.99
1.9
1.5
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
30
154
1.95
2.98
1.3
1.5
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
77
514
1.51
2.98
1.5
1.3
—
19.5
—
0
13
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
33
176
1.88
2.94
1.5
1.5
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
33
176
1.88
2.94
1.5
1.5
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
33
176
1.88
2.94
1.5
1.5
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
33
176
1.88
2.94
1.5
1.5
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
28
141
1.99
2.94
1.0
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
31
162
1.92
2.94
1.1
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
31
162
1.92
2.94
1.1
1.0
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
11
35
3.15
2.92
1.0
1.2
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
69
452
1.53
2.92
1.5
1.3
u/ml
109.4
121.9
0.60
13
88
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
130
961
1.36
2.90
1.5
1.4
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
17
70
2.43
2.87
1.2
1.0
—
—
—
0
0
(3017937) Magnesium [Moles/time] in 24 hour Urine
6
9
6.67
2.86
1.3
1.3
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
42
244
1.73
2.86
1.2
1.1
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
24
116
2.07
2.82
2.8
2.1
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
24
116
2.07
2.82
2.8
2.1
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
20
90
2.23
2.79
1.2
1.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
89
621
1.44
2.78
1.5
1.5
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
64
418
1.54
2.76
1.7
1.4
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
37
210
1.77
2.74
5.5
3.1
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
42
248
1.70
2.71
1.7
1.5
—
—
—
0
0
(44790048)
59
380
1.56
2.71
1.6
1.4
—
—
—
0
0
(44806118)
59
380
1.56
2.71
1.6
1.4
—
—
—
0
0
(44790047)
59
380
1.56
2.71
1.6
1.4
—
—
—
0
0
(44790049)
59
380
1.56
2.71
1.6
1.4
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
13
48
2.71
2.71
3.3
3.1
u/field
0.5
0.6
0.20
13
48
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
3198
30946
1.11
2.71
22.8
15.1
ml/min/173m2
74.0
74.2
0.20
2733
25607
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
43
257
1.68
2.66
1.2
1.1
—
68.7
—
0
12
(3006922) Hepatitis E virus Ab [Presence] in Serum
31
168
1.85
2.66
1.1
1.1
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
60
390
1.55
2.66
4.7
3.2
—
—
—
0
0
(3023383) Lactate [Moles/volume] in Pleural fluid
25
126
1.99
2.65
1.4
1.4
mmol/l
2.4
3.4
2.13
25
116
(3020191) Ethanol [Moles/volume] in Serum or Plasma
36
205
1.76
2.64
2.1
1.3
promille
1.5
1.2
0.68
29
158
(40757373) Influenza virus identified in Isolate
19
86
2.21
2.63
1.3
1.5
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
16
67
2.39
2.62
1.1
1.1
%
76.2
83.2
—
10
34
(3044941) Cell count panel - Synovial fluid
81
563
1.45
2.61
1.4
1.4
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
57
369
1.55
2.58
3.1
3.5
%
59.2
58.0
0.14
35
222
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
49
306
1.61
2.58
1.5
1.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
49
306
1.61
2.58
1.5
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
49
306
1.61
2.58
1.5
1.5
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
61
402
1.52
2.55
1.3
1.3
nmol/l
—
—
—
0
0
(3024932) HLA-DR beta [Type]
14
56
2.50
2.52
1.1
1.1
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
10
33
3.03
2.52
1.4
1.3
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
37
216
1.72
2.51
1.5
1.3
mmol/l
11.0
11.8
0.23
20
63
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
87
618
1.42
2.51
1.5
1.4
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
94
677
1.40
2.50
1.4
1.3
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
37
217
1.71
2.47
2.3
2.0
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
7
16
4.38
2.47
3.7
6.1
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
14
57
2.46
2.44
1.1
1.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
43
264
1.63
2.43
1.2
1.2
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
37
219
1.69
2.40
1.1
1.2
—
—
—
0
0
(3024471) HLA-A [Type]
14
58
2.42
2.36
1.0
1.0
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
71
492
1.45
2.36
1.1
1.1
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
55
362
1.53
2.34
1.3
1.4
mosm/kgh2o
279.8
277.4
0.26
45
261
(3045142) Bone marrow Pathology biopsy report
61
411
1.49
2.33
1.1
1.3
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
21
105
2.00
2.30
1.2
1.1
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
14
59
2.38
2.29
1.9
1.5
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
92
672
1.38
2.28
1.2
1.2
mmol/l
4.3
3.8
2.59
87
622
(37021550) Renin [Units/volume] in Plasma --upright
16
72
2.23
2.27
1.4
1.3
mu/l
93.9
56.4
—
10
53
(3025315) Body weight
8
23
3.48
2.26
3.9
4.2
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
19
92
2.07
2.26
2.1
1.7
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
38
232
1.64
2.22
2.1
2.4
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
14
60
2.34
2.21
1.1
1.1
—
—
—
0
0
(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine
5
9
5.56
2.21
1.0
1.2
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
13
54
2.41
2.19
1.2
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
64
442
1.45
2.18
1.2
1.3
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
33
195
1.70
2.18
2.1
2.2
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
26
143
1.82
2.18
1.7
1.6
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
123
1583
0.77
2.17
1.3
1.4
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
99
739
1.35
2.16
1.8
1.8
iu/l
5.9
4.4
0.42
35
240
(40768793) Breast Pathology biopsy report
52
768
0.67
2.16
1.3
1.3
—
—
—
0
0
(4024509)
58
395
1.47
2.13
1.9
1.6
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
634
7027
0.89
2.13
3.1
3.3
ug/l
0.8
0.8
0.00
446
5025
(3045414) Leukocytes [Presence] in Urine
193
1576
1.23
2.11
2.2
2.0
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
15
68
2.21
2.10
1.1
1.1
%
77.7
80.9
—
9
36
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
34
205
1.66
2.10
2.0
2.2
%
13.7
14.0
0.04
17
79
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
70
496
1.42
2.10
1.6
1.4
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
113
867
1.31
2.06
1.6
1.6
e6/l
10586.8
15123.8
0.86
79
620
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
413
3620
1.15
2.05
2.5
2.4
ug/l
5.4
6.8
0.96
331
3071
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
19
96
1.98
2.05
1.1
1.2
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
25
140
1.79
2.00
1.6
1.6
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
25
140
1.79
2.00
1.6
1.6
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
3696
36214
1.11
1.99
36.5
23.2
e9/l
6.9
6.9
0.17
3579
34898
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
33
201
1.65
1.98
2.0
2.2
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
334
2891
1.17
1.97
4.3
4.2
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
31
186
1.67
1.97
2.5
1.7
umol/l
27.3
8.5
0.59
24
118
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
27
156
1.73
1.96
1.4
1.1
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
3693
36193
1.11
1.95
36.5
23.2
e9/l
249.5
244.1
4.21
3584
35028
(3041672) Baker's yeast Ab [Presence] in Serum
5
11
4.55
1.94
1.0
1.0
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
35
218
1.61
1.93
2.8
1.8
u/field
2.2
2.3
0.04
30
149
(3027231) Wheat IgE Ab [Units/volume] in Serum
9
33
2.73
1.93
1.0
1.0
—
—
—
0
0
(3034459) Mononuclear cells/100 leukocytes in Pleural fluid
11
45
2.45
1.92
1.2
1.4
%
70.1
74.6
0.20
11
39
(3004451) EKG impression Narrative
32
195
1.65
1.92
1.2
1.3
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
15
71
2.12
1.92
2.3
2.3
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
15
71
2.12
1.92
1.0
1.1
—
—
—
0
0
(3024731) MCV [Entitic volume]
3693
36202
1.10
1.91
36.4
23.1
fl
91.5
91.7
1.27
3616
35445
(3035941) MCH [Entitic mass]
3693
36204
1.10
1.90
36.3
23.1
pg
30.1
30.4
14.86
3615
35445
(3026361) Erythrocytes [#/volume] in Blood
3693
36205
1.10
1.90
36.5
23.2
e12/l
4.2
4.4
78.48
3572
34903
(3024891) Influenza virus A+B Ag [Presence] in Specimen
107
827
1.30
1.88
1.3
1.2
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
3693
36212
1.10
1.87
36.9
23.3
g/l
125.4
133.1
160.44
3612
35468
(43055514) Macroprolactin [Presence] in Serum or Plasma
9
34
2.65
1.86
1.4
1.6
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
41
268
1.53
1.86
1.2
1.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
26
431
0.60
1.86
1.5
1.7
—
—
—
0
0
(40761535) Cells panel - Urine sediment
368
3226
1.15
1.85
3.7
3.6
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
72
526
1.37
1.85
1.7
1.4
e6/l
1264.1
2373.6
1.49
55
386
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
69
501
1.38
1.84
1.9
1.5
—
—
—
0
0
(4281824)
51
351
1.46
1.82
1.1
1.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
27
160
1.69
1.81
1.1
1.2
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
88
666
1.33
1.81
1.5
1.4
e6/l
1096.6
1237.9
0.07
79
549
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
40
262
1.53
1.81
1.5
1.3
titre
102.0
70.0
—
5
23
(4146454)
58
410
1.42
1.80
3.0
2.6
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
22
123
1.79
1.79
3.0
2.6
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
99
764
1.30
1.78
1.3
1.3
mg/l
476.6
559.9
1.80
91
718
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
54
378
1.43
1.77
2.6
2.1
u/field
2.7
2.0
0.39
29
128
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
166
1364
1.23
1.77
1.0
1.0
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
52
362
1.44
1.76
1.1
1.1
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
17
88
1.94
1.74
1.6
1.9
—
—
—
0
0
(3036603) Volume of Urine
34
217
1.57
1.73
1.7
1.4
ml
1426.8
1635.5
—
10
57
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
39
257
1.52
1.73
1.5
1.4
u/l
29.5
31.5
0.13
31
212
(3023323) Follitropin [Units/volume] in Serum or Plasma
105
821
1.29
1.72
1.3
1.3
iu/l
34.8
33.5
0.13
85
698
(3044290) Cell count panel - Cerebral spinal fluid
80
603
1.33
1.71
1.3
1.4
—
—
—
0
0
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
17
89
1.91
1.69
1.6
2.1
%
31.4
29.4
0.17
17
80
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
87
665
1.31
1.69
1.4
1.4
e6/l
13.5
26.2
0.57
75
521
(40768806) Pleura Pathology biopsy report
62
450
1.38
1.68
1.6
1.6
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
191
1603
1.20
1.66
2.7
2.7
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
57
409
1.40
1.65
2.0
1.5
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
78
589
1.33
1.65
1.5
1.5
g/l
29.6
31.2
0.53
69
530
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
45
309
1.46
1.65
2.1
1.6
u/ml
27.7
25.6
—
10
74
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
31
196
1.59
1.65
1.2
1.3
u/ml
3.0
1.3
0.24
15
104
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
24
142
1.69
1.64
1.4
1.1
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
65
478
1.36
1.64
1.7
1.4
e6/l
10839.1
65779.4
2.39
40
285
(3009214) Lutropin [Units/volume] in Serum or Plasma
66
488
1.36
1.61
1.5
1.3
u/l
16.0
11.5
1.34
54
387
(3022806) Fractional oxyhemoglobin in Capillary blood
68
506
1.35
1.60
2.2
1.8
%
88.0
89.4
0.71
68
500
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
8
32
2.50
1.59
1.0
1.0
—
—
—
0
0
(3035880) pH of Pleural fluid
36
238
1.52
1.59
1.3
1.4
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
34
222
1.54
1.59
1.1
1.1
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
15
77
1.95
1.59
2.0
1.3
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
7
26
2.69
1.58
1.1
1.2
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
73
552
1.33
1.55
1.6
1.4
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
40
273
1.47
1.53
1.5
1.4
titre
280.0
420.0
—
7
28
(3005570) Glucose [Moles/volume] in Urine
54
390
1.39
1.53
2.0
2.0
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
59
433
1.37
1.52
1.9
1.6
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
50
690
0.72
1.51
1.5
1.5
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
17
93
1.83
1.51
2.2
1.8
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
40
274
1.46
1.51
2.0
2.1
ml
609.6
601.9
0.05
28
171
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
17
94
1.81
1.47
1.6
2.1
e6/l
9313.4
10064.3
—
7
55
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
68
515
1.33
1.45
2.1
2.1
mg/l
35.5
23.4
0.99
26
116
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
6
22
2.73
1.43
1.2
1.1
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
12
59
2.04
1.43
1.7
1.9
e6/l
2825.7
152.2
—
7
23
(40757494) Bilirubin.total [Moles/volume] in Blood
32
212
1.51
1.43
2.2
2.2
umol/l
17.4
26.6
—
9
17
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
277
3145
0.87
1.42
1.6
1.6
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
35
237
1.48
1.41
1.9
2.5
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
41
287
1.43
1.40
1.7
1.9
—
1.3
—
0
15
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
9
40
2.25
1.40
1.2
1.2
—
—
—
0
0
(3014891) Appearance of Pleural fluid
13
67
1.94
1.38
1.4
1.4
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
26
166
1.57
1.37
2.2
2.6
%
41.0
39.4
0.16
12
59
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
482
4392
1.11
1.35
4.8
4.7
%
34.4
33.3
1.34
350
2828
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
13
68
1.91
1.33
1.2
1.1
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
13
68
1.91
1.33
1.3
1.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
85
673
1.27
1.33
1.1
1.1
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
11
54
2.04
1.32
1.9
1.1
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
12
61
1.97
1.32
1.0
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
55
411
1.34
1.30
1.3
1.3
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
100
809
1.24
1.30
1.7
1.5
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
6
24
2.50
1.30
1.0
1.0
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
8
34
2.35
1.29
1.1
4.6
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
28
185
1.52
1.28
2.0
1.6
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
31
210
1.48
1.27
1.6
1.5
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
194
1676
1.16
1.27
1.3
1.3
u/ml
250.5
203.3
0.24
183
1529
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
8
35
2.29
1.26
1.0
1.7
—
—
—
0
0
(3044889) 12 lead EKG panel
2482
24133
1.06
1.26
4.6
4.1
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
25
163
1.54
1.22
1.2
1.1
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
144
1219
1.19
1.21
4.1
3.7
mmol/l
3.9
3.9
0.28
129
1130
(3037556) Urate [Mass/volume] in Serum or Plasma
19
116
1.64
1.21
1.7
1.3
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
23
148
1.56
1.19
1.3
1.4
%
63.7
61.6
—
6
19
(3022689) Creatine [Moles/volume] in Urine
15
86
1.75
1.18
1.8
1.5
—
—
—
0
0
(40768443) Skin Pathology biopsy report
181
1566
1.16
1.18
1.3
1.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
69
542
1.28
1.18
1.6
1.3
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
12
64
1.88
1.18
2.0
1.4
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
20
125
1.60
1.17
1.3
1.3
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
14
79
1.77
1.16
1.0
1.1
—
—
—
0
0
(3026692) Albumin [Mass/volume] in Peritoneal fluid
14
79
1.77
1.16
1.1
1.5
g/l
15.7
13.7
—
9
61
(3014271) Vancomycin [Susceptibility]
34
240
1.42
1.15
3.2
3.0
—
—
—
0
0
(4268621)
35
249
1.41
1.14
2.3
2.3
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
28
191
1.47
1.13
1.5
1.7
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
47
354
1.33
1.10
1.2
1.2
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
7
32
2.19
1.08
2.0
1.5
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
42
314
1.34
1.04
1.0
1.1
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
13
75
1.74
1.02
1.3
1.6
ug/l
11.6
8.8
0.98
13
75
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
28
197
1.42
0.99
2.1
2.2
ug/min
282.6
147.1
—
8
48
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
60
476
1.26
0.98
1.1
1.1
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
11
61
1.80
0.98
2.6
2.7
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
5
23
2.17
0.98
1.2
1.0
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
5
23
2.17
0.98
1.0
1.1
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
61
487
1.26
0.96
1.7
1.4
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
6
27
2.22
0.93
1.0
1.4
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
17
109
1.56
0.93
2.2
2.2
e6/l
766.2
968.0
0.22
11
79
(3034891) Synovial lining cells/100 cells in Synovial fluid
22
150
1.47
0.92
1.6
1.4
%
1.6
5.0
—
5
33
(3019832) Treponema pallidum Ab [Presence] in Serum
154
1347
1.15
0.92
1.8
1.5
—
—
—
0
0
(4010399)
265
2399
1.11
0.91
1.4
1.4
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
72
590
1.22
0.91
2.0
1.6
mu/l
360.7
307.6
0.51
66
542
(3044007) Cell count panel - Peritoneal fluid
14
86
1.63
0.90
1.4
2.0
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
228
2050
1.12
0.89
4.6
3.7
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
24
168
1.43
0.89
1.2
1.1
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
29
2.07
0.89
4.2
5.4
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
34
254
1.34
0.88
2.3
1.9
mmol/l
7.8
6.9
0.66
23
165
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
14
87
1.61
0.87
1.7
1.2
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
8
43
1.86
0.87
1.1
1.1
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
15
95
1.58
0.87
1.4
1.9
—
—
—
0
0
(3003338) MCHC [Mass/volume]
2732
26792
1.05
0.86
33.2
20.9
g/l
328.7
331.5
39.76
2692
26458
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
23
161
1.43
0.86
1.1
1.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
905
8633
1.06
0.85
1.7
1.6
mmol/l
1.3
1.3
0.13
767
7183
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
419
3894
1.08
0.84
1.5
1.4
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
56
451
1.24
0.84
2.7
4.5
umol/l
324.8
348.9
0.62
46
388
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
8
45
1.78
0.84
1.1
1.1
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
102
873
1.17
0.83
1.8
1.7
mg/l
4.8
3.4
0.52
86
634
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
8
138
0.58
0.83
1.1
1.4
—
1.4
—
0
10
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
39
301
1.30
0.82
1.1
1.1
—
1.9
—
0
6
(3002523) Influenza virus A Ag [Presence] in Specimen
23
319
0.72
0.82
1.4
1.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
130
1136
1.15
0.81
5.8
4.5
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
23
318
0.72
0.81
1.4
1.1
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
27
198
1.37
0.80
1.1
1.1
nmol/l
1.5
7.0
—
9
48
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
305
2806
1.09
0.79
3.4
2.7
ml/min/173m2
59.7
61.4
0.39
153
1210
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
27
0.00
0.77
0.0
1.0
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
948
9882
0.95
0.76
4.4
4.7
%
21.6
22.2
0.59
440
5248
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
6
34
1.77
0.76
1.8
1.3
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
6
34
1.77
0.76
2.7
1.1
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
6
34
1.77
0.76
2.7
1.1
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
6
34
1.77
0.76
2.7
1.1
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
25
184
1.36
0.73
4.9
3.8
—
—
—
0
0
(4212803)
7
38
1.84
0.73
1.0
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
164
1468
1.12
0.73
2.2
1.8
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
5
25
2.00
0.72
1.2
1.1
—
—
—
0
0
(3019174) dRVVT (LA screen)
5
25
2.00
0.72
1.2
1.1
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
10
60
1.67
0.72
8.5
2.0
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
5
26
1.92
0.70
1.2
1.4
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
20
275
0.73
0.70
1.6
1.5
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
97
842
1.16
0.69
4.2
3.5
mg/l
30.6
28.3
0.28
64
548
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
448
4760
0.93
0.69
10.3
7.9
—
—
—
0
0
(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid
5
27
1.85
0.68
1.0
1.0
—
24.9
—
0
7
(3012441) Differential panel - Pleural fluid
53
438
1.21
0.67
1.6
1.5
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
147
1317
1.12
0.66
2.1
1.7
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
17
119
1.43
0.66
2.3
2.2
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
36
285
1.27
0.66
1.1
1.1
—
21.1
—
0
5
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
5
28
1.79
0.66
1.2
1.1
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
52
430
1.21
0.65
2.5
1.9
u/l
57.6
2085.5
3.72
23
173
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
45
367
1.23
0.65
1.2
1.2
u/ml
3.1
5.2
1.06
27
157
(3000492) Spirometry study
286
2655
1.08
0.64
1.5
1.5
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
36
287
1.26
0.63
1.8
1.7
—
—
—
0
0
(3002256) Pathology report gross observation
482
4563
1.06
0.62
1.4
1.3
—
—
—
0
0
(3041918) Cholesterol [Moles/volume] in Pleural fluid
12
79
1.52
0.62
1.0
1.2
mmol/l
1.6
1.6
—
7
57
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
15
104
1.44
0.62
1.5
1.2
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
35
279
1.26
0.62
1.4
1.7
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
11
71
1.55
0.62
1.2
1.1
umol/24h
0.6
0.7
—
6
35
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
5
30
1.67
0.61
2.2
2.3
mg/l
1.3
1.1
—
5
21
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
8
50
1.60
0.61
2.3
1.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
18
130
1.39
0.61
1.2
1.1
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
39
316
1.24
0.60
1.6
1.4
%
28.4
28.8
0.02
25
204
(3044416) Complement C4 [Mass/volume] in Pleural fluid
0
20
0.00
0.60
0.0
1.0
—
0.1
—
0
14
(4211845)
26
200
1.30
0.60
4.8
3.6
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
8
51
1.57
0.60
1.4
1.5
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
84
732
1.15
0.60
2.2
1.7
—
—
—
0
0
(3034426) Prothrombin time (PT)
12
80
1.50
0.59
1.2
1.3
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
8
52
1.54
0.59
1.1
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
32
254
1.26
0.59
1.1
1.0
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
23
0.00
0.58
0.0
1.3
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
49
409
1.20
0.58
3.7
3.6
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
858
8268
1.05
0.58
1.4
1.3
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
19
140
1.36
0.58
1.1
1.1
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
30
237
1.27
0.58
1.1
1.2
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
6
35
1.71
0.57
1.2
1.1
umol/24h
1.3
1.7
—
6
35
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
6
36
1.67
0.56
1.0
1.1
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
174
1593
1.10
0.55
3.8
3.7
u/ml
53.1
71.2
0.55
169
1530
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
20
150
1.33
0.55
1.0
1.0
u/l
1.2
1.1
—
7
81
(40768800) Prostate Pathology biopsy report
71
814
0.87
0.54
1.2
1.2
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
23
293
0.78
0.52
1.1
1.1
u/ml
0.1
1.2
—
10
113
(3020891) Body temperature
173
1591
1.09
0.51
5.4
4.2
—
—
—
0
0
(46235168) Fasting glucose [Moles/volume] in Blood
6
40
1.50
0.51
3.3
1.8
mmol/l
7.6
8.8
—
6
25
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
15
203
0.74
0.51
1.7
1.5
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
38
315
1.21
0.50
2.1
1.5
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
6
41
1.46
0.50
1.2
1.2
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
6
41
1.46
0.50
2.2
1.6
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
211
1962
1.08
0.49
2.0
2.1
nmol/l
12.4
11.8
0.46
190
1680
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
12
84
1.43
0.49
1.2
1.1
—
—
—
0
0
(44806420)
18
136
1.32
0.49
2.7
2.3
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
62
542
1.15
0.46
2.9
2.7
—
—
—
0
0
(4015189)
14
103
1.36
0.45
1.5
2.2
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
12
86
1.40
0.44
1.1
1.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
381
3997
0.95
0.44
1.4
1.4
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
13
95
1.37
0.43
1.2
1.5
—
2029800.0
—
0
5
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
10
140
0.71
0.43
1.4
1.5
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
22
175
1.26
0.43
1.1
1.0
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
44
377
1.17
0.43
1.2
1.2
u/ml
2.0
4.2
1.09
22
119
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
12
87
1.38
0.42
1.1
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
12
87
1.38
0.42
1.1
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
12
87
1.38
0.42
1.1
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
12
87
1.38
0.42
1.1
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
12
87
1.38
0.42
1.1
1.1
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
5
33
1.52
0.41
1.4
2.3
umol/l
13.2
19.3
—
5
33
(3014051) Protein [Presence] in Urine by Test strip
93
842
1.11
0.41
2.4
2.3
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
31
260
1.19
0.39
2.7
5.2
u/ml
50.3
48.0
—
8
72
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
10
71
1.41
0.39
1.7
1.6
—
—
—
0
0
(3024263) Appearance of Synovial fluid
25
205
1.22
0.39
1.8
1.6
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
25
206
1.21
0.37
4.6
3.6
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
30
355
0.84
0.37
1.3
1.3
mmol/l
7.4
7.7
0.19
22
250
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
59
524
1.13
0.37
1.1
1.3
miu/ml
255.3
211.0
0.32
20
217
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
3127
31531
0.97
0.37
4.7
4.6
mmol/l
1.4
1.5
7.24
2843
28351
(3051593) INR in Capillary blood by Coagulation assay
26
216
1.20
0.36
6.7
16.8
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
25
300
0.83
0.36
1.1
1.1
u/ml
1.6
3.6
1.11
12
133
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
3160
31854
0.97
0.36
4.7
4.6
mmol/l
4.3
4.5
45.51
2902
28862
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
6
43
1.40
0.35
1.3
1.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
33
283
1.17
0.34
1.6
1.5
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
13
100
1.30
0.33
1.2
1.0
u/ml
0.4
1.2
—
8
27
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
15
188
0.80
0.33
4.3
6.6
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
6
86
0.70
0.33
3.0
2.9
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
29
248
1.17
0.31
1.1
1.0
ng/l
692.6
662.5
0.14
18
153
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
29
248
1.17
0.31
1.1
1.0
ng/l
246.6
314.9
0.85
18
158
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
3251
32277
1.02
0.31
5.3
4.9
mmol/l
6.2
6.0
6.45
2924
28734
(3016018) Differential panel - Cerebral spinal fluid
35
305
1.15
0.30
1.5
1.3
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
12
93
1.29
0.30
1.1
1.1
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
29
250
1.16
0.29
1.1
1.0
ng/l
28.5
44.9
1.72
18
156
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
33
377
0.87
0.29
1.0
1.1
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
17
139
1.22
0.29
1.2
1.1
—
—
—
0
0
(4094501)
92
853
1.08
0.28
1.1
1.1
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
13
103
1.26
0.28
1.2
1.1
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
11
85
1.29
0.28
1.1
1.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
84
777
1.08
0.27
1.3
1.4
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
38
338
1.13
0.26
1.4
1.3
e6/l
161592.8
118059.5
0.12
26
236
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
9
72
1.25
0.25
1.2
1.2
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
16
192
0.83
0.25
1.6
1.5
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
25
216
1.16
0.25
2.2
1.4
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
15
123
1.22
0.25
1.2
1.2
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
35
311
1.13
0.25
1.1
1.2
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
13
105
1.24
0.24
2.5
2.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
3026
30450
0.98
0.24
4.2
4.1
mmol/l
1.3
1.3
0.88
2725
27106
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
12
96
1.25
0.24
1.6
1.3
%
25.5
24.8
—
6
12
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
25
217
1.15
0.24
2.2
1.4
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
24
208
1.15
0.24
1.5
1.9
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
3258
32754
0.98
0.23
5.4
5.2
mmol/l
2.4
2.6
35.26
2974
29520
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
156
1636
0.95
0.23
1.3
1.3
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
11
88
1.25
0.22
1.7
1.8
ug/l
0.7
1.3
1.20
11
83
(44813793)
21
181
1.16
0.22
1.0
1.0
—
—
—
0
0
(3007542) Rye IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
0.2
—
0
5
(3013762) Body weight Measured
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(37019676) Renin [Units/volume] in Plasma --supine
0
13
0.00
0.21
0.0
1.1
—
11.9
—
0
7
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
31
345
0.90
0.20
1.2
1.1
u/ml
0.3
1.8
1.77
12
132
(3051101) Glucose [Moles/volume] in Cord blood
10
80
1.25
0.20
5.4
5.8
—
—
—
0
0
(3013945) Hepatitis B virus e Ab [Presence] in Serum
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
11
133
0.83
0.19
1.0
1.2
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
6
51
1.18
0.19
1.0
1.0
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
11
90
1.22
0.19
1.1
1.0
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
60
560
1.07
0.18
2.4
1.7
—
—
—
0
0
(4034850)
106
1113
0.95
0.18
11.9
11.3
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
16
185
0.86
0.18
1.7
1.4
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
46
425
1.08
0.18
1.5
1.5
—
—
—
0
0
(4133840)
7
61
1.15
0.17
1.0
1.1
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
16
184
0.87
0.17
1.6
1.4
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
38
349
1.09
0.17
1.1
1.1
%
115.1
114.0
0.07
32
307
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
5
67
0.75
0.17
1.0
1.2
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
10
120
0.83
0.16
1.0
1.0
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
8
68
1.18
0.16
45.3
9.4
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
8
68
1.18
0.16
1.5
1.1
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
6
77
0.78
0.15
1.3
1.1
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
6
78
0.77
0.15
1.7
1.6
—
—
—
0
0
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
6
79
0.76
0.15
1.3
2.4
nmol/l
76.7
161.3
—
6
69
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
9
82
1.10
0.15
1.2
1.4
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
9
82
1.10
0.15
1.1
1.1
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
11
129
0.85
0.14
5.8
5.1
—
60.0
—
0
27
(3014599) Egg white IgE Ab [Units/volume] in Serum
11
94
1.17
0.13
1.1
1.1
u/ml
0.5
0.4
—
5
21
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
82
856
0.96
0.13
1.2
1.2
—
—
—
0
0
(4306422)
38
356
1.07
0.11
1.2
1.2
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
63
660
0.95
0.11
1.4
1.4
pmol/l
112.1
213.8
2.00
63
640
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
190
1854
1.03
0.11
1.3
1.3
au/ml
42.6
52.6
—
7
80
(3023419) Bacteria identified in Sputum by Culture
51
485
1.05
0.10
2.4
2.3
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
33
309
1.07
0.10
1.5
1.3
u/l
8.8
12.4
1.57
27
286
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
27
251
1.08
0.10
2.1
1.4
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
5
45
1.11
0.09
2.8
1.5
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
5
47
1.06
0.09
1.0
1.0
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
16
176
0.91
0.09
1.3
1.5
%
59.5
67.9
0.65
11
143
(3025018) Bordetella pertussis Ab [Titer] in Serum
16
145
1.10
0.09
1.2
1.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
82
793
1.03
0.09
1.0
1.1
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
58
558
1.04
0.08
1.8
1.7
nmol/l
57.0
44.7
2.30
58
532
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
22
236
0.93
0.08
1.6
1.5
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
7
68
1.03
0.07
1.0
1.6
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
12
133
0.90
0.07
1.3
1.4
pmol/l
89.8
68.2
—
5
43
(1002224) Polysomnography panel
90
925
0.97
0.07
1.1
1.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
16
173
0.92
0.06
1.7
1.7
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
79
811
0.97
0.06
2.3
1.7
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
9
105
0.86
0.06
1.0
1.3
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
12
109
1.10
0.06
1.3
1.2
g/l
47.2
38.6
—
6
52
(1617658) Protocol used for examination of sentinel lymph nodes
27
284
0.95
0.06
1.0
1.0
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
21
223
0.94
0.06
1.6
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
21
223
0.94
0.06
1.6
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
21
222
0.95
0.05
1.5
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
21
222
0.95
0.05
1.5
1.4
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
19
179
1.06
0.04
3.6
2.3
mmol/l
8.8
9.2
0.15
13
143
(3001019) Free T4 and TSH panel - Serum or Plasma
104
1023
1.02
0.04
2.0
1.8
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
209
2069
1.01
0.04
2.4
2.4
au/ml
31.1
26.6
—
6
81
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
1235
12317
1.00
0.03
4.9
5.5
ug/l
3.5
4.4
0.61
1066
10904
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
18
171
1.05
0.03
1.2
1.2
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
10
92
1.09
0.03
1.1
1.1
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
14
140
1.00
0.00
1.1
1.2
ratio
1.1
1.0
—
6
46
(3023511) Choriogonadotropin [Units/volume] in Urine
20
200
1.00
0.00
1.1
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
36
364
0.99
0.00
1.1
1.1
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
22
221
1.00
0.00
1.0
1.0
u/ml
0.8
2.9
—
9
82
(4027681)
15
148
1.01
0.00
1.2
1.2
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
16
164
0.98
0.00
1.3
1.3
mmol/l
6.9
6.1
0.81
16
156
(3023430) Cat dander IgE Ab [Units/volume] in Serum
20
204
0.98
0.00
1.1
1.1
u/ml
0.7
3.5
—
10
78
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
19
189
1.01
0.00
1.1
1.0
u/ml
0.1
0.4
—
5
53
(3010726) Horse dander IgE Ab [Units/volume] in Serum
26
258
1.01
0.00
1.1
1.1
u/ml
0.2
2.4
—
8
63
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013862) HLA-DP [Type]
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
6
61
0.98
0.00
1.2
1.1
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
7
79
0.89
0.00
1.0
1.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
6
59
1.02
0.00
1.0
1.1
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018291) Platelet Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
8
89
0.90
0.00
2.0
1.3
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
8
81
0.99
0.00
45.3
8.8
—
—
—
0
0
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
7
72
0.97
0.00
1.0
1.1
—
5.2
—
0
10
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
7
73
0.96
0.00
1.4
1.6
—
—
—
0
0
(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
1.4
—
0
5
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015147) Influenza virus A IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
8
89
0.90
0.00
1.6
1.1
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
8
80
1.00
0.00
1.1
1.1
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
5
54
0.93
0.00
7.0
9.1
—
—
—
0
0
(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
9
90
1.00
0.00
1.1
1.1
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
7
73
0.96
0.00
1.7
1.1
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002079) Sodium [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
129.9
—
0
5
(3008640) Bordetella pertussis IgG Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint D3_ANAEMIA_B12_DEF and mortality.

Females

Parameter HR [95% CI] p-value
D3_ANAEMIA_B12_DEF 1.482 [1.37, 1.6] < 0.001
Birth year 0.992 [0.98, 1.0] 0.055

During the follow-up period (1.1.1998 — 31.12.2019), 7706 out of 16915 females with D3_ANAEMIA_B12_DEF died.

Males

Parameter HR [95% CI] p-value
D3_ANAEMIA_B12_DEF 1.604 [1.46, 1.76] < 0.001
Birth year 0.989 [0.98, 1.0] 0.015

During the follow-up period (1.1.1998 — 31.12.2019), 6887 out of 13361 males with D3_ANAEMIA_B12_DEF died.

Mortality risk

Mortality risk for people of age

years, who have D3_ANAEMIA_B12_DEF.

N-year risk Females Males
1 0.147% 0.38%
5 0.848% 2.113%
10 2.174% 5.004%
15 4.043% 9.139%
20 6.83% 15.193%

Relationships between endpoints

↥

Index endpoint: D3_ANAEMIA_B12_DEF – Vitamin B12 deficiency anaemia

GWS hits: 14

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data